Appetitive memories and relapse to drug-use: investigations on effects of selective disruption of memory mechanisms in a rat model of nicotine dependence. by AUBER ALESSIA
 
 
 
 
UNIVERSITA’ DEGLI STUDI DI VERONA 
FACOLTA’ DI MEDICINA E CHIRURGIA 
Dipartimento di Patologia e Diagnostica 
 
 
SCUOLA DI DOTTORATO DI 
Scienze Biomediche Traslazionali 
 
DOTTORATO DI RICERCA IN 
Biomedicina Traslazionale 
CICLO XXIV 
 
TITOLO DELLA TESI DI DOTTORATO 
APPETITIVE MEMORIES AND RELAPSE TO DRUG-USE: 
INVESTIGATIONS ON EFFECTS OF SELECTIVE DISRUPTION OF 
MEMORY MECHANISMS IN A RAT MODEL OF NICOTINE DEPENDENCE  
S.S.D BIO14/FARMACOLOGIA 
 
 
Coordinatore: Chiar.mo Prof. Cristiano Chiamulera 
Tutor: Chiar.mo Prof. Cristiano Chiamulera 
 
                           Dottoranda: 
                                             Dott.ssa Alessia Auber
 2 
Abstract 
Tobacco use through cigarette smoking is the leading preventable cause of death in the 
developed world. The pharmacological effect of nicotine plays a crucial role in tobacco 
addiction. Nicotine dependence has a huge impact on global health and although several 
medications are available, including a wide range of nicotine-replacement therapies 
(NRTs), bupropion, and recently approved nicotinic receptor partial agonist varenicline, 
at best only about a fifth of smokers are able to maintain long-term (12 months) 
abstinence with any of these approaches. Thus, there is a need to identify more effective 
treatment to aid smokers in maintaining long-term abstinence.  
Several preclinical and clinical studies have underlined the importance of non-
pharmacological factors, such as environmental stimuli, in maintaining smoking 
behaviour and promoting relapse. Initially neutral stimuli that are repeatedly paired with 
a reinforcing drug (e.g. lighter) acquire a new conditioned value (conditioned stimuli, 
CS) and become able to elicit craving even in the absence of the drug. Indeed smokers 
are particularly reactive to smoking/nicotine related CS, this phenomenon is called cue-
reactivity and involves a vast array of physiological, psychological and also behavioural 
response, such as decrease in heart rate and blood pressure and/or increase in skin 
conductance and skin temperature, increase in craving and urge to smoke and/or mood 
change, and also change in smoking behaviour (e.g., latency to smoke, cigarette puff 
volume and frequency, amount of cigarette consumed and relapse to smoking 
behaviour). Given the importance of the learned association between stimuli and 
nicotine in the phenomenon of relapse to nicotine-seeking behaviour, it has been 
proposed that treatment that disrupts the nicotine-associated memories could act as a 
pro-abstinent and anti-relapse therapy.  
After learning experience, memories are stored by a process called consolidation. For at 
least a century it has been a dogma that initially labile memory (short-term memory) are 
consolidated by the passage of time and become stable and permanent (long-term 
memory). However converging evidence from animal and human studies have revealed 
that memories may return to a vulnerable phase during which they can be updated, 
maintained and even disrupted. The retrieval of memory indeed may destabilize the 
consolidated memories that require a new process to be maintained. This hypothetical 
process is called reconsolidation. The disruption of drug-related memories 
reconsolidation has been proposed as a potential therapeutic target to prevent the CS-
 
 
3 
induced relapse in ex drug-addicts.  Several animal studies have shown that the 
reconsolidation of drug-related memories can be disrupted by the administration of an 
amnestic drug contingently upon retrieval of the memory. Unfortunately most of the 
compound used in animal studies has serious tolerability and safety issues in humans. 
Recently Monfils at al and Schiller et al have shown that it is possible to disrupt fear 
memory reconsolidation and consequently prevent the return of fear by providing CS-
extinction training shortly after retrieval of the memory. CS-extinction consists in the 
repeated presentations of CS (e.g. lighter) in the absence of the unconditioned stimulus 
US (e.g. drug) leading to a decrease of the previously acquired conditioned response 
(e.g. smoking behaviour).  
The main objective of the present thesis was to investigated whether it is possible to 
disrupt nicotine related memories reconsolidation by applying CS-extinction after the 
retrieval of such as memories, and whether this disruption prevent the relapse to 
nicotine-seeking behaviour in a rat model of nicotine dependence. Furthermore we 
investigated also whether nicotine-related memories reconsolidation might be 
pharmacologically disrupted by administering a drug, that have been shown to disrupt 
memory reconsolidation in previous literature studies (i.e. propranolol or MK-801), at 
memory retrieval.  
The experimental approach used to address this issue was the paradigm of nicotine self-
administration in rats, a paradigm based on Pavlovian and operant conditioning to 
nicotine and nicotine-associated cues. We performed five experiments in which CS-
extinction or the pharmacological treatment (i.e. propranolol or MK-801) was 
associated to different memory retrieval protocols. We therefore assessed the effect of 
these post-retrieval treatments on relapse to nicotine or food seeking behaviour. 
Retrieval consists in presenting the CS in the absence of US, a procedure similar to CS- 
extinction. Since the length of CS exposure  (i.e. number of CS presentations) is a 
crucial factor for reconsolidation or extinction occurrence, different retrieval length (1, 
3 or 30 CS presentations) have been presented to retrieve nicotine-related memories.  
Results showed that CS-extinction applied after a short retrieval (3 CS presentations) 
reduced the relapse to nicotine seeking behaviour compared to control groups that did 
not receive CS-extinction, moreover this effect was not observed when CS-extinction 
was applied without retrieval. These results suggest that the effect of post-retrieval CS-
extinction was specifically due to inhibition of nicotine-related memories 
reconsolidation. To our knowledge, this is the first evidence of post-retrieval CS-
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extinction effect on drug-seeking behaviour. Considering that this is an indirect 
demonstration of the occurrence of memory reconsolidation process, we would also 
consider these findings as the first evidence of nicotine Pavlovian memory 
reconsolidation. On the other hand, no effect of MK-801 or propranolol on nicotine 
seeking behaviour has been observed. These results are in contrast with other literature 
data, however methodological issues might explain the contrasting results. 
More evidences are needed to confirm that the effect of post-retrieval CS-extinction was 
due to interference of CS-extinction with reconsolidation process. Further studies will 
investigate the effect of CS-extinction applied 6 hours after retrieval, a delay time that 
allows to apply CS-extinction outside the labile phase of memory due to retrieval. 
Moreover it would be fundamental to identify specific molecular markers of 
reconsolidation or extinction. To find a selective molecular correlate of reconsolidation 
will allow to disentangle the point of whether our retrieval protocols are inducing 
reconsolidation or extinction and will provide further evidence that post-retrieval CS-
extinction interfere with reconsolidation of CS-memory. This could also be useful to 
better understand the lack of effect of MK-801 and propranolol in our experiments.  
It has been pointed out by Lee & Everitt (2008) that to successfully reactivate a memory 
acquired instrumentally (as in our experiments) the CS should be presented contingently 
upon acquired response. We can then hypothesized that presenting the CS contingently 
upon response during retrieval session, would lead to a more strong retrieval and 
destabilization of the memories, and to a stronger effect of CS-extinction and of MK-
801 on the reconsolidation of that memory.  
Finally, it would be important to assess whether the effect of post-retrieval CS-
extinction on nicotine seeking behaviour is persistent, by repeating the test several week 
after retrieval-CS-extinction procedure. 
In conclusion, our findings suggest that the exposure to nicotine CS-extinction, after a 
short retrieval of the same nicotine CS, may inhibit CS-induced relapse to nicotine-
seeking behaviour and may offer a potential co-adjuvant to current therapeutic 
interventions for smoking cessation and abstinence maintenance. 
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1. INTRODUCTION 
Tobacco use is the leading global cause of preventable and premature death. It is one of 
the main causes for a number of chronic diseases, including cancer, lung diseases, and 
cardiovascular diseases. Cigarette smoking is also a risk factor for respiratory tract 
infections, reproductive disorders, osteoporosis, adverse postoperative events such as 
delayed wound healing, duodenal and gastric ulcers and diabetes (Vineis et al, 2004). 
Tobacco use kills nearly 6 million people and causes hundreds of billions of dollars of 
economic damage worldwide each year. If the current trends continue, by 2030 tobacco 
will kill more than 8 billion people worldwide each year (World Health Organization 
Report 2011). Seventy percent of smokers say that they would like to quit, eighty 
percent who attempt to quit on their own return to smoking within a month, and each 
year, only 3% of smokers quit successfully.  
Smoking-related diseases are a consequence of prolonged exposure to toxins in tobacco 
smoke; therefore the most dangerous aspect of smoking is that constituents are highly 
addictive.  
Tobacco addiction is reported both in the Diagnostic and Statistical Manual of Mental 
Disorders, 4th edn. and in the World Health Organization’s International Classification 
of Diseases, version 10. 
The criteria for defining drug dependence are the following: 
Primary criteria: 
• Highly controller or compulsive use 
• Psychoactive effects 
• Drug-reinforced behaviour 
Additional criteria: 
• Addictive behaviour often involves 
-Stereotypic patterns of use 
-Use despite harmful effects 
-Relapse following abstinence 
-Recurrent drug cravings 
• Dependence-producing drugs often produce 
-Tolerance 
-Physical dependence 
-Pleasant (euphoriant) effects. 
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Tobacco dependence fit all the above criteria. It is a behavioural disorder due to chronic 
exposure to a psychoactive substance, nicotine (Abrams et al., 1999). Importantly, 
smokers do not just self-administer nicotine while smoking, but they experience the 
pharmacological effect of nicotine in a context rich of environmental stimuli. Indeed, 
tobacco addiction arises from an interplay of i) pharmacological effect of nicotine, ii) 
psychological and physiological susceptibility of the individual (e.g. genetic 
predisposition, psychiatric disorder, impulsivity) and iii) social and environmental 
influences (including tobacco product and marketing) (Caggiula et al., 2001, Field et al., 
2009; Karp et al., 2006; Pomerlau, 1995; Rodriguez et al., 2007). 
 
1.1. Neurobiology of Nicotine 
1.1.1. Absorption 
Nicotine is an alkaloid that constitutes approximately 0.6–3.0% of the dry weight of 
tobacco. It is a psychoactive addictive drug. Inhalation of smoke from a cigarette distils 
nicotine from the tobacco in the cigarette. Smoke particles carry nicotine into the lungs, 
where it is rapidly absorbed into the pulmonary venous circulation. The nicotine then 
enters the arterial circulation, rapidly crosses the blood barrier in approximately 7-10 
seconds and move into the brain, where it binds to nicotinic cholinergic receptors 
(nAChR) (Hukkanen et al., 2005).  
 
1.1.2 Nicotinic cholinergic receptors and neuroadaptation 
nAChR is a ligand-gated ion channel that normally binds acethylcholine (Albuquerque 
et al., 2009). It consists in five peptidic subunits: the mammalian brain expresses nine α 
subunits and three β subunits. Usually the receptor is composed of two α and three β 
subunits arranged to form a pore (Jensen et al., 2005). The receptor α4β2 is the most 
abundant and the principal mediator of nicotine dependence. Ligand binding occurs via 
the α subunit, producing a conformation change that opens the cationic channel and 
allow sodium and calcium ion influx, after few milliseconds the channel close and 
become desensitised. In the absence of agonist, the receptor return to the standby stage 
where it is closed but “activable”. Moreover chronic nicotine exposure increases 
nicotine or acethylcholine (ACh) binding in the brain, a phenomenon known as up-
regulation. 
When brain nicotine levels decrease, e.g. during abstinence, the up-regulated 
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receptors return to the standby state leading to a hyperexcitability of cholinergic 
system. This hyperexcitability is associated with withdrawal effect: the symptoms of 
craving and withdrawal, indeed, begin in smokers when the up-regulated 
desensitized α4β2 receptors become responsive during a long period of abstinence, 
such as overnight. Nicotine binding of these receptors during smoking alleviates 
craving and withdrawal (Dani & Heinemann, 1996). Smokers regulate the daily 
amount of cigarette smoking in order to maintain near-complete saturation, and thus 
desensitization, of the α4β2 receptors. Thus smokers are probably attempting to 
avoid withdrawal syndrome when maintaining a desensitized state.  
  
1.1.3 Nicotine and neurotrasmitters release 
nAChRs are localized mainly at presynaptic level on a number of different type of 
neurons, such as on glutamatergic, on dopaminergic, noradrenergic and gamma 
aminobutyric acid (GABA) neurons in the ventral tegmental area (VTA), substantia 
nigra, and striatum (Figure 1). Thus nicotine modulates not only ACh level but also 
dopamine (DA), glutamate and GABA activity (Albuquerque et al., 1997; Alkondon et 
al., 1997; Gray et al., 1996; Guo et al., 1996; Ji et al., 2001; Jones et al., 1999; Jones & 
Wonnacot, 2004; Li et al., 1998; Mansvelder & McGehee, 2000; Marubio et al, 2003; 
McGehee & Role, 1995; McGehee et al., 1995; Radcliffe & Dani, 1988; Radcliffe et al., 
1999; Role & Berg, 1996; Wonnacott, 1997, Yin and French, 2000)  
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Figure 1: Schematic drawing of dopaminergic, gabaergic, glutamatergic and cholinergic 
neurons interaction. nAChRs are localized mainly at presynaptic level on glutamatergic, 
dopaminergic, and gabaergic neurons. Abbreviations in the text, except D1 = dopamine 
receptor 1, mGluR2/3 = metabotropic glutamate receptor type 2or 3. Image taken from 
Balfour, 1994. 
 
 
It is widely accepted that nicotine dependence, similarly to other drugs of abuse (such as 
cocaine, amphetamine, etc.), arises from nicotine action on dopaminergic neurons in the 
mesocorticolimbic system. This system is also called reward pathway and involves 
dopaminergic neurons located in VTA and their projection into the striatum, amygdala, 
prefrontal cortex and the shell of nucleus accumbens (Figure 2).  
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Figure 2: Schematic drawing of mesocorticolimbic pathway, mediating nicotine 
dependence.  Nicotine stimulates nAChR located in the VTA, resulting in release of DA 
in the nucleus accumbens. Neurons projecting from the prefrontal cortex and amygdala 
modulate the release of DA in the nucleus accumbens. GABAergic neurons projections 
modulate DA release in nucleus accumbens and VTA. Image taken from Le Foll & 
George, 2007. 
 
 
It has been well established that the activation of mesocorticolimbic DA pathways is 
associated with drug reward (Di Chiara, 2000), where increased neuronal firing in the 
VTA (Clarke, 1990; French, et al., 1996) and DA release in the nucleus accumbens (Di 
Chiara and Imperato, 1988) are neurochemical correlates of psychostimulant self- 
administration. Laboratory animals self-administer nicotine, indicating that the drug 
exerts effects on mesocorticolimbic DA neurotransmission in a comparable manner to 
other psychostimulant drugs of abuse. Supporting a predominant role for enhanced 
dopaminergic neurotransmission, nicotine concentrations self- administered by rodents 
and humans also increase DA release in the nucleus accumbens (Imperato, et al., 1986; 
Nisell, et al., 1994) and activate DA neurons in the VTA (Pidoplichko, et al., 1997). 
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Moreover it has been shown that inhibition of DA release in nucleus accumbens by 
antagonist drugs attenuates reinforcing properties of nicotine, leading to a decrease in 
nicotine self-administration in rats (Corrigal & Coen, 1989; Stolerman & Shoaib, 
1991.). 
 As stated above, nicotine also augments both glutamate and GABA release: the former 
one facilitates DA release, the latter inhibit DA release. Chronic exposure to nicotine 
induces desensitization of some types of nAChR, but not all. As a results GABA 
inhibitory action diminishes while glutamate-mediated excitation persists, leading to an 
increase dopaminergic neurons firing and enhancement in responsiveness to nicotine 
(Mansvelder & McGhee, 2000, 2002).  
Nicotine also affects the release of endogenous opioid peptides. Nicotine binding to 
nAChR within hypothalamus induces the release of a precursor of ß-endorphin. It is 
thought to be involved in mood regulation, decrease response to stress, conserve energy 
and relaxation (Cesselin, 1995). 
As far as concerns serotonergic transmission, it has been shown that chronic nicotine 
exposure produces a selective decrease in the concentration of 5-HT in the hippocampus 
(Benwell & Balfour, 1979). The effect of this neuroadaptation is still unclear, however, 
considering the findings that 5-HT deficits have been implicated in depression and 
anxiety, it may be hypothesized that during chronic nicotine exposure and withdrawal, 
the decrease in serotonin function play a role in the onset of negative affective 
symptoms, such as depressed mood and irritability (Schwartz, 1984). 
 
1.1.4 Nicotine effects and withdrawal 
The activation of peripheral nAChRs increases noradrenaline release, with concomitant 
increases in heart rate, blood pressure, and respiratory rate. Centrally nicotine improves 
working memory functions, learning and attention; it also induces pleasure and reduces 
stress and anxiety. At the initial experience it can give nausea/disorientation. 
After a first experience of smoking, as a result of pharmacological and non-
pharmacological factors, an individual frequently elect to repeat the experience (Rose, 
2006). This leads to the next stage where the prolonged exposure to smoke induce a 
neuroadaptation in the brain, increasing the reinforcing effects of nicotine (Soria, et al., 
1996). When CNS nicotine levels ceases abruptly following smoking cessation, it 
produce temporary imbalances in neurological systems before compensatory 
mechanisms are triggered to restore homeostasis (Lowinson, 2005). This imbalance is 
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associated with unpleasant withdrawal effects such as irritability, headache, nausea, 
constipation or diarrhoea, falling heart rate and blood pressure, fatigue, drowsiness or 
insomnia, depression, increased hunger and energy, lack of concentration, anxiety, and 
cravings for cigarettes (Benowitz, 1988) which are powerful incentives to take 
up/relapse smoking again (Hughes, 1992; Hughes et al., 1984; 1991) Thus basis of 
nicotine addiction is a combination of positive reinforcement of mood and avoidance of 
withdrawal symptoms. In addition, conditioning has an important role in the 
development of tobacco addiction. 
 
1.1.5 Pharmacological smoking cessation treatment 
First-line pharmacological treatments of tobacco dependence recommended by clinical 
practice guidelines are nicotine replacement therapy (NRT), bupropion and varenicline 
(Lerman et al., 2007). 
Nicotine replacement therapy (NRT) is the only first-line smoking cessation treatment 
available without prescription and has increased short-term smoking cessation rates by 
50–70% (Rigotti, 2002). NRT reduces the severity of withdrawal symptoms such as 
anxiety, insomnia, depressed mood, and inability to concentrate (Ford and Zlabek, 
2005). Smoking whilst using NRT provides a deterrent, as the high nicotine doses can 
produce aversive effects such as nausea, palpitations, hypotension, and altered 
respiration (Frishman, 2007). NRT treatments are available as a nasal spray, chewing 
gum or transdermal patches.  However, despite initial benefits, around 95% of ex-
smokers who had undergone transdermal patch NRT relapsed after a period of time 
(Clinical Practice Guideline Treating Tobacco Use and Dependence 2008 Update Panel, 
Liaisons, and Staff.  U.S.A. Public Health Service report. Am J Prev Med. 2008 35:158-
76.).  
Bupropion is an antidepressant drug; its primary pharmacological action is thought to be 
noradrenergic and dopaminergic reuptake inhibition. It binds selectively to DA 
transporter, but its behavioural effects have often been attributed to its inhibition of 
noradrenaline reuptake (Balfour, 2011). It also acts as a nAChRs antagonist. Its efficacy 
might be explained by its antidepressant effect, indeed depression is a withdrawal 
symptom that reliably predict relapse among abstinent smokers (Hughes, 2007). 
Moreover, its antagonist-like activity on nAChR decreases the reinforcing effect of 
nicotine. 
Varenicline is nAChR partial agonist. It activates DA reward system with less abuse 
 14 
liability of nicotine. Indeed it produce a lesser, slower DA release then nicotine with a 
longer duration if action, Moreover, when varenicline is combined with nicotine, it 
attenuates nicotine induced DA release in nucleus accumbens (Rolleman et al., 2007). 
Behavioural interventions play an integral role in smoking cessation, either in 
conjunction with medication or alone. They employ a variety of methods to assist 
smokers in quitting, ranging from self-help materials to individual cognitive-
behavioural therapy. These interventions teach individuals to recognize high-risk 
smoking situations, develop alternative coping strategies, manage stress, improve 
problem solving skills, as well as increase social support (Clinical Practice Guideline 
Treating Tobacco Use and Dependence 2008 Update Panel, Liaisons, and Staff. U.S.A. 
Public Health Service report. Am J Prev Med. 2008 35:158-76.). 
 
1.2 Psychobiology of tobacco addiction 
The severity of nicotine dependence (abuse liability, frequency of consumption, high 
rate of relapse) is similar to other drug dependence, such as opiates or cocaine. In 
contrast, the reinforcing properties of nicotine is subtler compared to other drug. It 
suggests that the reinforcing effect of nicotine is necessary but not sufficient to explain 
tobacco dependence (Caggiula, 2001). Furthermore several preclinical and clinical 
studies have underlined the importance of non-pharmacological factors, such as 
environmental stimuli, in maintaining smoking behaviour and promoting relapse. 
 
1.2.1 Conditioning 
A stimulus that is repeatedly and contingently paired with an unconditioned stimulus 
(e.g. nicotine effect) acquires a Pavlovian conditioned value (Pavlov, 1927). Thus with 
regular smoking within a complex individual and social context, smokers associate 
specific situation, mood or environmental factors with the rewarding effect of nicotine. 
These smoking-associated stimuli may trigger physiological, psychological and 
behavioural reactivity in smokers, and it is widely accepted that they can precipitate 
relapse in ex-addicts (Abrams, 1999; Drummond, 2000; Niaura et al., 1988). There are 
two classes of conditioned stimuli: proximal discrete cues that become conditioned 
stimuli (CS) after association to drug effects (e.g. cigarettes, lighter), and distal stimuli 
that are present in the environmental context (e.g. bar and people around) (Conklin et 
al., 2008). 
 
 
 
15 
1.2.2 Nicotine’s multiple-action 
Several studies suggest that in addition to its primary reinforcing properties, nicotine 
has a second effect that may be important in promoting smoking behaviour. Nicotine is 
a cognitive enhancer drug and may enhance the salience of other reinforcers, including 
the CS that has acquired conditioned values by repeated pairing with nicotine effect 
(Caggiula et al, 2002). Nicotine activates and potentiates information processing at 
those brain area and pathway where reinforcement and sensory transmission are 
integrated into emotional, motivational and cognitive processes that control for smoking 
behaviour. Smoking behaviour may therefore be maintained by a “multiple-action” 
effect of nicotine: i) as a primary reinforcement and ii) as an enhancer of the multiple 
smoking/smoking-associated stimuli processing. This model may help to explain how 
nicotine could play a central role in initiation, maintenance and difficulty to stop 
smoking, despite of its mild reinforcing properties (Chiamulera, 2005). 
 
1.2.3. Cue reactivity 
Cue reactivity is the vast array of responses that are observed when addicts or ex-
addicts are exposed to drug-related CS (Drummond, 2000). These responses can be i) 
physiological, such as decrease in heart rate and blood pressure and/or increase in skin 
conductance and skin temperature, ii) psychological, such as increase in craving and 
urge to smoke and/or mood change, iii) and also behavioural, such as cigarette-seeking 
and change in smoking behaviour (e.g. latency to smoke, cigarette puff volume and 
frequency, amount of cigarette consumed and relapse to smoking behaviour). Several 
factors may influences smokers’ cue reactivity: type of stimuli (e.g. distal vs. proximal) 
(Conklin et al, 2008), degree of nicotine dependence (Payne et al, 1996) impulsivity, 
genetic, comorbidity (Drummond, 2000), contextual factor drug-availability or 
expectation (Field & Duka, 2001).  
Several brain imaging studies have revealed that brain area of the mesocorticolimbic 
system are specifically activated in smokers exposed to smoking-associated stimuli, and 
that these effects may overlap with those induced by nicotine administration. The fact 
that exposure to smoking cues and nicotine administration activate similar brain patterns 
suggests a causal relationship between nicotine effect through smoking and 
development/ maintenance of cue reactivity (Yalachkov et al, 2009). Cue reactivity may 
last in ex smokers even after years of smoking cessation, and is the main cause of 
relapse to smoking behaviour (Shiffman, 2009). 
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1.3 Nicotine-related memories 
Given the importance of the learned association between stimuli and drug, that we can 
also call drug-associated memories, in the phenomenon of relapse to drug-seeking 
behaviour, it has been proposed that treatment that disrupt the drug-associated 
memories could act as a pro-abstinent and anti-relapse therapy (Diergaarde, 2008; 
Tronson &Taylor, 2007; Taylor, 2011). Therefore there is an increasing interest in 
investigate the phenomena of drug memories consolidation and reconsolidation. 
 
1.3.1 Reconsolidation theory 
Memories are stored after a learning experience through a process called consolidation. 
For more than 100 years the idea that once consolidated memories become permanently 
stored in the wiring of the brain has been a dogma. In the traditional consolidation 
theory new memory are initially in a  “labile” form for a short time (short term memory-
STM), after which the memory trace is fixed or “consolidated” into the physical 
structure of the brain (long term memory-LTM). In 1968 Lewis and colleagues 
observed that an electroconvulsive shock (an amnestic treatment), provided after the 
memories have been reactivated by its retrieval, could induce amnesia the following 
day. Given that amnesia was not produced in the absence of memory reactivation it has 
been argued that retrieval of memory induce a reactivation of the memory trace, that 
presumably return to a labile state, which initiated another memory process similar to 
that seen after learning. The processes through which memory are maintained after 
retrieval is called reconsolidation (Figure 3).  
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Figure 3: Two model of memory processing. (a) The traditional consolidation memory 
that stated that a labile short-term memory (STM) and a later, consolidated, permanent 
long-term memory (b) The memory model proposed by Lewis (1968). The active state 
(AS) and inactive state (IS) are analogous to STM and LTM, respectively.  Memory 
after learning experience are in AS, then it enter in IS by the passage of time.  Retrieval 
of the memory returns it to the AS (Nader, 2003). 
 
 
Furthermore it has been shown that amnesia can be induced only if the amnestic 
treatment, such as the electroconvulsive shock, is given shortly after retrieval (Misanin 
et al, 1968; Schneider & Sherman; 1968). These findings suggest that retrieval induce a 
transient labile phase of the memory, the time during which memory trace are labile is 
called reconsolidation window and persist for several hours after retrieval (Duvarci & 
Nader, 2004; Nader et al, 2000; Sara, 2000). 
In the past 10 years the study of reconsolidation have been extended to numerous 
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The idea that new memories are initially ‘labile’ and
sensitive to disruption before becoming permanently
stored in the wiring of the brain has been dogma for
>100 years. Recently, we have revisited the hypothesis
that reactivation of a consolidated memory can return it
to a labile, sensitive state – in which it can be modified,
strengthened, changed or even erased! The data gener-
ated from some of the best-described paradigms in
memory research, in conjunction with powerful neuro-
biological technologies, have provided striking support
for a very dynamic neurobiological basis of memory,
which is beginning to overturn the old dogma.
For .100 years, generations of behavioural paradigms
and technologies have been used to address questions
about the mechanisms that mediate learning and memory
[1–3]. Repeatedly, evidence has been found to suggest that
the properties of the memory trace change in a time-
dependent manner, such that new memories are initially
in a dynamic ‘labile’ form for a short time [short-term
memory (STM)], after which the memory trace is ‘fixed’ or
‘consolidated’ into the physical structure of the brain [long-
term memory (LTM)] [4–6]. For example, electroconvul-
sive shock (ECS) is effective in inducing amnesia if
presented shortly after training (during STM) but not if
given a few hours later (during LTM) [7]. Time-dependent
effects such as these are the cornerstone of memory
consolidation theory (now called cellular consolidation
theory [8]). During the past 40 years, incredible efforts
have been made to describe across all levels of analysis
the processes that contribute to the transformation of a
trace from being labile to being fixed [9,10]. Of note is
the finding that the transcription factor Ca2þ-response-
element-binding protein (CREB), transcription and trans-
lation all seem to be universal neuronal requirements for
traces to enter LTM [11–15] (Fig. 1a).
Early studies on reconsolidation
In 1968, the view that memories are consolidated over
time into a permanent state was challenged by Lewis
and colleagues [16]. In agreement with previous studies,
when ECS was given 24 h after fear conditioning it was
ineffective in generating amnesia. However, if the memory
was reactivated before ECS administration, amnesia was
observed the following day. Given that amnesia was not
produced in the absence of memory reactivation, the
memory is defined as being consolidated by that time.
Therefore, reactivation of a consolidated memory presum-
ably returned it to a labile state, which initiated anoth r
time-dependent memory process similar to that seen after
new learning. This phenomenon is now referred to as
reconsolidation [17–19]. Lewis’ study defined a paradigm
for experimentally differentiating consolidation and recon-
solidation: a necessary criterion if an effect is to be attri-
buted to reconsolidation is that the amnesic agent must be
Fig. 1. Two models of memory processing. (a) The traditional consolidation theory,
which p sits a labile, short-ter memory (STM) state and a later, consolidated
long-term memory (LTM) state. Once fixed in LTM, the memory is posited to be
permanent. Below each memory state is a list that is typically used to describe
some of the properties of the two states. (b) The memory model proposed by
Lewis [33]. The active state (AS) and inactive state (IS) are analogous to STM and
LTM, respectively. The molecular descriptors in brackets were not part of the
original model but have been inserted for comparison with (a). New memories
enter a labile AS and then with time enter the IS [top red arrow, again similar to
(a)]. Reactivation of memories that are in an IS returns them to the AS (bottom red
arrow). Both new and reactivated memories require protein-synthesis-dependent
mechanisms in order to enter the IS. Contrary to consolidation theory, which
cannot explain the reconsolidation data, this model incorporates both the data
fro consolidation and reconsolidation experiments.
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species, including crabs, chicks, honey bees, etc. and to numerous experimental 
paradigms (Figure 4). 
 
Figure 4: Example of experimental paradigms and treatment and species involved for 
studies that reported evidence of reconsolidation process since 2000. (Modified from 
Nader  & Hardt, 2009).  
 
 
To experimentally demonstrate reconsolidation or the role of a particular molecule in 
reconsolidation memories must be first consolidated, then reactivated (retrieved) 
contiguously with some form of manipulation. Finally, modification of the memory 
must be observed.  
Reconsolidation is frequently studied using Pavlovian conditioning paradigms, such as 
fear conditioning. Training consists of pairing a neutral stimulus (conditioned stimulus-
cue), such as a tone, with a reinforcing stimulus (unconditioned stimulus), such as a 
foot-shock. Retrieval is induced in a reactivation session, which occur at least 24 hours 
later and consists in presenting the conditioned stimulus in the absence of unconditioned 
stimulus. The manipulation (such as the administration of an amnestic drug) is applied 
either prior or immediately after the reactivation session. Finally at least 24 hours later 
the memory is tested by re-presenting the cues and measuring the unconditioned 
responding, in this case the freezing (measure of fear response), compared with animal 
reactivation-dependent interference effects in consoli-
dated episodic memory were found only when human 
subjects were exposed to the interfering material in the 
same environment in which the original learning took 
place. Thus, activating memory outside the spatial learn-
ing context was not sufficient to induce reconsolidation.
So-called boundary conditions are physiological, envi-
ronmental or psychological situations in which memory 
that normally would reconsolidate does not. Several 
boundary conditions have been proposed, such as extinc-
tion consolidation65,66,68, memory age67,68, predictability 
of the reactivation stimulus74,75 and training intensity68. 
However, these results remain controversial, as other 
studies were unable to replicate them (for extinction see 
REFS 69,70; for old memories see REFS 37,77; for predict-
ability of the reactivation stimulus see REFS 36,40,58,78; 
and for strength of training see REFS 37,77). 
Therefore, it remains to be seen whether additional 
parameters moderate boundary conditions.
There is currently no universally applicable recon-
solidation protocol to reliably destabilize consolidated 
memory, which in turn complicates establishing bound-
ary conditions. If under certain conditions reconsolida-
tion effects are not detected, one cannot conclude with 
certainty that a boundary condition has been found. 
For example, in contextual fear conditioning, memo-
ries that were acquired with a strong training protocol 
of three shocks did not undergo reconsolidation if the 
reactivation session took 3 or 5 minutes, but reactivat-
ing memory for 10 minutes triggered reconsolidation68. 
If only the two shorter reactivations had been used, the 
absence of reconsolidation might have been taken as 
evidence that memories acquired with strong training 
do not undergo reconsolidation, implying a true bound-
ary condition. This kind of parametric manipulation has 
not been performed for most proposed boundary con-
ditions suggested by certain experimental results. It is 
thus unclear whether these conditions are true boundary 
conditions or merely situations in which it is harder than 
normal to induce reconsolidation.
Alternative interpretations
Reconsolidation, as discussed above, has been defined 
using the very standards that define consolidation. 
Therefore, questioning certain aspects of the reconsoli-
dation hypothesis poses the same challenges for the con-
solidation hypothesis. The reconsolidation hypothesis in 
its current form has come under considerable scrutiny. 
We now discuss some of the alternative interpretations 
of the data that have been proposed in the literature.
Lesion or nonspecific effects. One theory posits that the 
amnesic treatment induces a lesion and thus impairs 
reactivated consolidated memory79 (FIG. 3). This sugges-
tion explains the deficits in PR-LTM and, if the treat-
ment took several hours to destroy the local tissue and 
produce the lesion, it might explain the intact PR-STM. 
However, amnesic animals can be retrained, demonstrat-
ing that the targeted brain structures remain functional80. 
Moreover, without memory reactivation the amnesic 
Table 1 | Some of the paradigms in which reconsolidation has been reported
Experimental paradigm Treatment Animal Refs
Habituation Heat shock, and DNQX (antagonist of non-NMDA-type glutamate receptor) Nematode 59
Auditory fear conditioning Protein synthesis inhibition, inhibition of kinase activity, and reconsolidation 
potentiation by protein kinase A activation
Rat 35,99,137
Classical fear conditioning Transient anaesthesia Medaka (a fish) 65
‘Pavlovian-like’ conditioning Protein synthesis inhibition, sensory block, mRNA synthesis inhibition and blocking 
bond formation of cell-adhesion molecules
Hermissenda 42
Contextual fear conditioning Protein synthesis inhibition, inducible CREB-knockout and antisense 
oligodeoxynucleotides
Rat and mouse 37–39
Context-signal memory NMDA receptor antagonist Crab 74
Operant conditioning RNA synthesis inhibition, and cooling Snail 40
Appetitive conditioning Protein synthesis inhibtion Honeybee 69
Conditioned taste aversion Protein synthesis inhibition Rat pups 138
Inhibitory avoidance Protein synthesis inhibition, glycoprotein synthesis inhibition and antisense 
oligodeoxynucleotides
Chicks and rats 67,87,139
Motor sequence learning Interference by new learning Humans 41
Incentive learning Protein synthesis inhibition Rat 140
Object recognition Zif268-deficient mouse, and inhibition of kinase activity Mouse, rat 36,141
Spatial memory Protein synthesis inhibition Mouse and rat 68,75
Memory for drug reward Inhibition of the ERK kinase MEK, Zif268-deficient knock-in mice and Zif268 antisense 
oligodeoxynucleotides
Rat and 
knock-in mouse
57,58,77
Episodic memory Interference by new learning Humans 72,76
This table lists example experimental paradigms and the treatments and species involved for studies that reported evidence of a reconsolidation process since 
2000. CREB, cAMP-responsiv  element-binding prot i ; DNQX, 6,7-dinitroquinoxaline-2,3-dione; ERK,extr cellular signal-r gulated kinase; MEK, MAPK/ERK 
kinase; NMDA, N-methyl-?-aspartate.
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in the non-manipulated control group. 
Demonstrating reconsolidation not only requires evidence of modification of a 
previously consolidated memory, but also evidence that in the absence of retrieval or if 
the amnestic manipulation is applied outside the reconsolidation window, the memory 
remains unmodified. 
To better understand the cellular a molecular mechanisms underlying of particular focus 
have been the molecular cascades previously demonstrated to be important in memory 
consolidation and those downstream of therapeutically relevant neurotransmitter targets 
including β -adrenergic receptors and NMDARs (N-methyl-d-aspartate receptors). De-
novo protein synthesis is required for memory reconsolidation; several animal studies 
have shown that injection of protein synthesis inhibitor, such as anisomycin, after 
retrieval of a previously consolidated memory, can disrupt the original memory. It has 
been shown that the immediate-early genes c-Fos and JunB are activated during, and 
CCAAT-enhancing binding protein-β (C/EBPβ) is required for, memory 
reconsolidation. The gene transcription is initiate by the activation of transcription 
factors such as cAMP response element-binding protein (CREB), zinc finger 268 (zif-
268), ELK1 and nuclear factor kB (NF-kB).  These, in turn, are activated by upstream 
kinase, such as extracellular-regulated kinase (ERK) and protein kinase A (PKA) (for 
review see Tronson & Taylor, 2007) (Figure 5). 
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Figure 5: Key molecular mechanisms of memory reconsolidation. Molecular signalling 
cascades downstream of β-adrenergic receptors (β-AR) and NMDARs (N-methyl-d-
aspartate receptors) have been shown to be implicated in reconsolidation. Small 
GTPases such as Ras, Raf and Rap activated by Ca2+ influx activate the extracellular 
signal-regulated kinase pathway (ERK). Protein kinase A (PKA) is activated by cyclic 
AMP (cAMP) and acts directly, or indirectly through ERK and ribosomal protein S6 
kinase (RSK), to activate transcription factors including cAMP response element-
binding protein (CREB), zinc finger 268 (ZIF268) and ELK1, which then initiate gene 
transcription. The immediate-early genes c-Fos and JunB are activated during, and 
CCAAT-enhancing binding protein-β (C/EBPβ) is required for, memory reconsolidation 
(image taken from Tronson &Taylor, 2007). 
 
 
From an evolutionary perspective, it has been argued that reconsolidation may serve as 
an adaptive update mechanism allowing for new information, available at the time of 
retrieval, to be integrated into the initial memory representation (Alberini, 2005; 
Hupbach et al, 2007; Monfils et al, 2009; Nader, 2002). Other authors proposed that 
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conditioned place preference38,48.
PKA is also required for reconsolidation of auditory 
fear memories. Inhibition of PKA in the BLA by infu-
sions of Rp-cAMPS, a PKA inhibitor, after memory 
retrieval disrupts auditory fear memories6 (FIG. 3) or 
conditioned taste aversion memories49. Moreover, post-
reactivation activation of PKA by injections of the PKA 
activator 6-BNZ-cAMP in the BLA enhances reconsoli-
dation of an auditory fear memory6. Unlike its involve-
ment in memory reconsolidation, amygdalar PKA does 
not seem to be involved in extinction of fear, indicat-
ing differential molecular or ana mical mechanisms 
in these two co-occurring processes6. However, PKA 
is not alw ys involved in reconsolidation in every spe-
cies; a recent study showed that retrieval of a memory 
shortly (6 hours) — but not 24 hours — after train-
ing triggers PKA-dependent reconsolidation50. At 
both times reconsolidation is PSI-dependent. This 
study extends previous models that have shown that 
older memories are more resistant to reconsolidation 
to suggest that, in addition, different processes are 
involved in reconsolidation of older than newer mem-
ories. Whether such differential involvement of PKA 
in memories at different times after training is true in 
mammalian models, or other types of memory, is as 
yet unknown.
Immediate-early genes. Molecular events in reconsolida-
tion have also been examined by imaging c llular ctiv-
Figure 2 | Key molecular mechanisms of memory reconsolidation. Many individual molecules have been identified as 
being required for memory reconsolidation; however, few papers have put together schematic models for the pathways 
involved. This figure integrates findings from several studies. Of particular focus have been the molecular cascades 
previously demonstrated to be important in memory consolidation and those downstream of therapeutically relevant 
neurotransmitter targets including β-adrenergic receptors (β-AR)70,71,87–90 and NMDARs9,60,91–93 (N-methyl-d-aspartate 
receptors). Molecular signalling cascades downstream of these receptors have been implicated in reconsolidation. Small 
GTPases such as Ras, Raf and Rap activated by Ca2+ influx activate the extracellular signal-regulated kinase pathway 
(ERK)38,46–48,94. Protein kinase A (PKA)6,49,50 is activated by cyclic AMP (cAMP) and acts directly, or indirectly through ERK and 
ribosomal protein S6 kinase (RSK), to activate transcription factors including cAMP response element-binding protein 
(CREB)15,37,38, zinc finger 268 (ZIF268) (REFS 41–45,51,52) and ELK1 (REF. 38), which then initiate gene transcription. The 
immediate-early genes c-Fos and JunB37,38,53–55 are activated during, and CCAAT-enhancing binding protein-β (C/EBPβ)30,34 
is required for, memory reconsolidation. Integrating all the available data aims to identify logical pathways to examine 
next. For example, a role for the calcium/calmodulin (CaM)–CaM-dependent protein kinase kinase (CaMKK)–CaMKIV 
cascade in memory reconsolidation might be inferred from NMDAR activity; however, the involvement of this pathway has 
not directly been examined. AP1, activator protein complex 1 (a complex of c-Fos and c-JUN); CBP, CREB binding protein; 
MEK, mitogen-activated protein kinase/ERK kinase; SRE, serine response element; SRF, serum response factor; TATA, box 
required for transcription. Figure modified, with permission, from Nature Reviews Neuroscience REF. 76  (2001) Macmillan 
Publishers Ltd.
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reconsolidation might serve to strengthen memory (Inda et al, 2011; Lee, 2009; Sara, 
2000). 
As stated above, it has been shown in several animal studies that memory could also be 
disrupted acting on the molecular mechanisms underlying reconsolidation (for review 
see Tronson and Taylor, 2000; Nader et al, 2000; Soeter & Kindt, 2011). This offers a 
potential for the treatment of psychiatric disorders characterized by strong pathogenic 
memories, such as post-traumatic stress disorders (PTSD), phobias and also drug 
addiction (Centonze et al, 2005). 
 
1.3.2 Reconsolidation as a potential target in drug addiction treatment 
Drug addiction is a chronic disorder characterized by a high rate of relapse to drug use 
among abstinent. One of the main causes of relapse is the exposure to the CS that are 
associated to drug effect in a Pavlovian manner and influence drug-seeking behaviour 
and relapse through the memory they evoke (Milton and Everitt, 2010). 
Therefore molecular and neuroanatomical processes involved in the reconsolidation of 
drugs-associated memories have been proposed as novel targets for the treatment of 
vulnerability to CS in drug addicts (Tronson & Taylor, 2007; Diergaarde et al., 2008; 
Taylor et al., 2009; Milton & Everitt, 2010). Mechanistic studies identified receptors, 
signalling molecules and transcription factors underlying drugs-associated memory 
reconsolidation (Sadler et al., 2007; Brown et al., 2007; Fricks-Gleason & Marshall, 
2008; Itzhak, 2008; Lee & Everitt, 2008; Milton et al., 2008a, 2008b; Fuchs et al., 2009; 
Ramirez et al., 2009; Sanchez et al., 2010; Théberge et al., 2010; Wu et al., 2011;). 
These studies have been focused mostly upon two neurotransmitters receptors, known 
to be involved in the reconsolidation of emotional memories: NMDA subtype of 
glutamate receptor and β-adrenergic receptor. 
It has been shown that NMDAR antagonist, such as MK-801 or D(-)-(2R)-amino-5-
phosphonovaleric acid (D-APV), given shortly after retrieval, may inhibit the 
reconsolidation of drug-associated memory in different Pavlovian conditioning 
paradigms in rats, such as conditioned place preference produced by cocaine (Kelley et 
al, 2007), amphetamine (Sandler et al, 2007; Sakurai et al, 2007), and morphine (Zhai et 
al, 2008); cue-induced reinstatement of alcohol seeking (von der Goltz at al, 2009); and 
the acquisition of a new instrumental response for a CS previously paired with cocaine 
(Milton et al, 2008).  It has been proposed that a reduction in the expression of the 
immediate-early –gene zif268 is linked to disruption of memory reconsolidation. Indeed 
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Milton and colleagues found that administration of the NMDAR antagonist D-APV into 
the basolateral amygdala before a memory reactivation disrupt the reconsolidation of 
cocaine-associated memory in rats trained to cocaine self-administration and this effect 
is associated with a reduction in the expression of zif268.  Also Lee (2005) showed that 
an infusion of the zif268 antisense oligodeoxynuclotides (ASO) into the basolateral 
amygdala contingently upon retrieval of cocaine-associated memory could disrupt the 
conditioned reinforcing value of the CS. However it has not yet been investigated 
through which signalling cascade (e.g. ERK activation or protein kinase A) expression 
of zif268 is linked to NMDAR. On the other hand, in rats trained to self-administer 
cocaine, systemic administration of MK-801 contingently upon retrieval, showed no 
effect on subsequent cocaine-primed reinstatement of cocaine-seeking behaviour 
(Brown et al, 2008).  
The first evidence of the role of β-adrenergic receptor in the reconsolidation of 
appetitive memory had been provided by Diegaarde and colleagues in 2006: in their 
work they showed that the administration of propranolol, an antagonist of β -adrenergic 
receptor, contingently upon retrieval, could reduce the context-induced reinstatement of 
sucrose seeking behaviour in rats trained to sucrose self-administration. Subsequently 
Milton and colleagues (2008) showed that the administration of propranolol in rats 
trained to self-administer cocaine resulted in a retrieval-dependent impairment in the 
acquisition of a new response for cocaine-conditioned reinforcement, suggesting that 
reconsolidation of cocaine-associated memories has been disrupted. Moreover it has 
been shown that propranolol, administered upon retrieval, could disrupt place 
preference conditioned by cocaine (Bernardi et al, 2006) morphine (Robinson & 
Franklin, 2007a). However propranolol, given at retrieval, failed in reducing cue-
induced reinstatement of cocaine seeking behaviour, following forced abstinence, in rats 
trained to cocaine self-administration (Milton & Everitt 2010). 
Unfortunately the drugs used to disrupt memory reconsolidation in animal cannot be 
used in human, since they are toxic. The only drug that can be administered in human is 
propranolol, even if it could lead to side effect, such as orthostatic hypothension, 
decreased libido, bronchial adverse effects in patients affected by respiratory disease. 
Since there is an unmet need of novel interventions to be integrated in the current 
therapy, a new strategy based on targeting reconsolidation should guarantee efficacy 
and tolerability. 
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1.3.3 Extinction therapy 
One of the most used cognitive-behavioural therapies for the treatment of anxiety 
disorder and to prevent the relapse in ex-drug addicts is extinction (also called Cue-
Exposure). Extinction consists in the repeated presentation of previously CS in the 
absence of unconditioned stimulus. It is widely accepted that extinction is a new 
learning process, through which CS become associated to no US, leading to a decrease 
of the conditioned response. Extinction does not erase the original associative (CS-US) 
memory but instead generate a competitive inhibitory memory capable of temporally 
suppressing the expression of the original conditioned response (Pavlov, 1927; Quirk & 
Mueller 2008; Pape and Pare, 2010). Indeed original memory and extinguished response 
may re-emerge under three general condition: i) reinstatement, when US is presented 
unexpectedly (Pavlov 1927; Rescorla and Heth 1975; Westbrook et al. 2002, de Wit & 
Steward, 1981, Shaham et al, 1994), ii) renewal, when CS is presented outside the 
extinction context (Bouton and Bolles 1979) and iii) spontaneous recovery, when a 
certain amount of time has passed.  
Several efforts have been dedicated to enhance the efficacy of extinction. It is widely 
acknowledged that glutamatergic NMDA receptor is directly involved in the formation 
of new learning and memories (Walker & Davis, 2002), and in early rodent studies it 
has been shown that a NMDA partial agonist D-cycloserine (DCS) may facilitate 
extinction (Liu et al, 2009; Falls et al, 1992; for review see Ganasen et al, 2010). Other 
compounds may be useful for strengthening or accelerating extinction, as suggested by 
recent rodent studies. These include fibroblast growth factor, methylene blue, 
endocannabinoids and yohimbine, N-acetylcysteine (Chatwal et al, 2009; Gonzales- 
Lima & Bruchey, 2004; Graham and Richarson, 2010; Morris & Bouton, 2007; Zhou & 
Kalivas, 2008). 
 
1.3.4 Extinction and reconsolidation interaction. 
Thus current research for the treatment of neuropsychiatric disorders based upon 
maladaptive memories, including drug addiction, is focused on the facilitation of 
extinction and on the disruption of maladaptive memory reconsolidation. 
Unfortunately the compounds used in animal studies to block the reconsolidation, such 
as protein synthesis inhibitor (eg., anisomycin) and NMDAR antagonist (such as 
MK801) cannot be used in human, given their toxicity and bioavailability constraints. 
Moreover the efficacy of pharmacological improvement of extinction therapy is 
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controversial (Marissen et al. 2007). 
 An important step forward came from Monfils and colleagues in 2009. Capitalizing on 
reconsolidation as an update mechanism that allow for new information available at the 
time of retrieval to be integrated in the original memory trace, they hypothesized that 
proving no-fearful information through extinction training during the labile phase 
induced by retrieval, would lead to a modification of the original memory, 
reinterpreting CS as safe and therefore would prevent the CS-induced return of fear. 
They trained rats to Pavlovian fear conditioning; 24 hours later fear memory was 
reactivated by a single presentation of CS; 10 minutes, 1 hour, 6 or 24 hours later 
animal underwent an extinction session while CS was repeatedly presented in the 
absence of US (non fearful information). The day after they tested the return of fear 
under reinstatement or renewal conditions and one month later they tested the 
spontaneous recovery of fear. Results showed that extinction, only when applied within 
the reconsolidation window (10 minutes or 1 hour after retrieval) but not when applied 
outside the reconsolidation window (6 or 24 hours after retrieval), interfered with fear 
memory update and prevented fear conditioned responses such as renewal, 
reinstatement and spontaneous recovery. Additionally rats that received extinction 
without retrieval of the CS showed re-emergence of fear under renewal, reinstatement 
and also spontaneous recovery. 
These findings were supported by the work of Schiller and colleagues in 2010. Using 
human electrodermal fear conditioning model they demonstrated that extinction, applied 
10 minutes after retrieval (single CS presentation) of a fear memory, prevented the 
spontaneous recovery and reinstatement of fear response. Conversely extinction applied 
6 hours after retrieval (outside the reconsolidation window) had no effect. 
These two studies suggest that a new learning may interfere with memory 
reconsolidation of the original memory, this notion has received support also from other 
studies targeting episodic, motor and declarative memories both in human and in 
laboratory animals. Boccia and co-workers in 2005 showed the exposure to a new 
learning task could affect the memory reconsolidation in an inhibitory avoidance task in 
mice. Forcato and colleagues in 2007, 2009 and 2010 demonstrated that new 
information provided within the reconsolidation window may modify the original 
declarative memories in human. There are evidences that also episodic memories could 
be selectively impaired following retrieval (Hupbach et al, 2007; Strange et al, 2010). 
Interestingly, Flavell et al. (2011) have recently shown extinction given in conjunction 
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to retrieval was able to block the reconsolidation of appetitive memory in rats. They 
have used the paradigm of acquisition of new response for stimuli previously paired to 
sucrose. In this experimental paradigm rats are initially trained to self-administer 
sucrose by an instrumental response (e.g. nose-poke), and each sucrose administration is 
paired with the presentation of a CS, such as a light or a tone. In a second phase, rats are 
required to acquire a new instrumental response (e.g. lever press) to receive a CS 
presentation. Therefore the new instrumental behaviour is supported by the conditioned 
reinforcing properties of the CS. In this study Flavell et al. showed that CS-extinction 
applied after the retrieval of the CS, inhibited the acquisition of new response in rats 
trained to self-administer sucrose. This effect was retrieval-dependent since no effect 
was observed when extinction was applied without previous retrieval of the CS. They 
hypothesized that extinction applied within the vulnerable phase of the retrieved 
memory, was interfering with their reconsolidation. However they also pointed out that 
it was equally plausible that prior retrieval of the memory might facilitate extinction and 
therefore potentiate its effect, in a similar manner to pharmacological enhancement of 
extinction. To disentangle this account in a new groups of rats they substitute retrieval 
with the administration of D-cycloserine (DCS), an NMDA receptor partial agonist, 
well know to enhance extinction of memory (see paragraph 1.3.3.). Results showed that 
when rats were injected with DCS, instead of being retrieved, before the administration 
of extinction there was no effect on subsequent acquisition of new response with 
conditioned reinforcer. Therefore they argued that the observed post-retrieval extinction 
effect was due to the interference with reconsolidation of sucrose-related memories. 
Furthermore Flavell et al investigated the effect on retrieval-extinction procedure on 
reconsolidation of contextual fear memory. They showed that extinction, only when 
applied in combination to retrieval, prevented the return of fear in the subsequent test. 
Further evidence that the effect of extinction was retrieval dependent came from the fact 
that injection nimodipine, a blocker of L-type voltage-gated calcium channel (LVGCC) 
known to block the destabilization of memory at retrieval, immediately after retrieval 
impaired the effect of retrieval-extinction in preventing the return of fear. This result 
provides further evidence that extinction applied after retrieval inhibits the re-
expression of the original memory by the disruption of memory reconsolidation. On the 
other Flavell and colleagues have also showed that the combination of memory retrieval 
and extinction did not prevent the return of fear, using the auditory fear conditioning 
paradigm. However they highlight that some methodological issues might explain the 
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contrasting results with the original finding of Monfils et al (such as training length).  
The molecular mechanism underlying the effect of post-retrieval extinction has been 
investigated by Clem & Huganir (2010), pairing fear conditioning paradigm and 
elettrophysiology assay. They trained animal in fear conditioning paradigm, the day 
after training memory was retrieved 30 minutes before extinction, and renewal and 
spontaneous tests performed the day after and also 5 days after retrieval-extinction. 
They observed that, compared to the no-retrieved groups, retrieval-extinction procedure 
inhibited the return of fear. Subsequently a groups of animal were injected with 1-
aminoindan-1,5-dicarboxylic acid (AIDA), a competitive antagonist of AMPA receptor 
mGluR1, 1 hour before retrieval. Post-retrieval extinction effect in preventing the return 
of fear was inhibited by the previous administration of AIDA. Thus, they argued that 
effect of extinction upon retrieval required the mGluR1 activation. In further 
electrophysiological studies they observed a significant decrease of AMPA receptors –
mediated transmission in the retrieved group compared to the no-retrieval group. This 
decrease was accompanied by the selective removal of synaptic calcium-permeable 
AMPA (CP-AMPAr) receptors in the lateral amygdala. Moreover the stability of CP-
AMPAr was regulated by the activation of mGluR1. Considering post-retrieval 
extinction effect as a reconsolidation update author suggest that mGluR1 activation is 
required to update memories, and that mGluR1 could be a potential drug target for 
preventing the return of fear. 
Other studies have shown that the retrieval-extinction paradigm used by Monfils and 
Schiller was ineffective in preventing the return of fear in fear conditioning paradigm 
both in human and in laboratory animals. This type of procedure allow to isolate the 
acquired conditioned Pavlovian conditioned reinforcing properties if CS, from the 
instrumental component of the conditioning (see below, operant and Pavlovian 
conditioning). 
First evidence came from a preclinical study by Chan and colleagues (2010): they use 
the same procedure described by Monfils et al (2009) to study the effect of a single CS 
presentation (retrieval) on the extinction and recovery of conditioned fear response via 
renewal and reinstatement in fear conditioning paradigm. Conversely to Monfils et al, 
they found that exposure to retrieval prior to extinction increased responding to that 
retrieved CS on subsequent test for renewal and reinstatement. The retrieval-extinction 
procedure has been also tested on remote fear memory (29 days old) in a mouse model 
of PTSD (Siegmund and Wotjak, 2007a), that compared to that used by Monfils et al, 
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take in consideration also the non associative component of fear memory (i.e. 
sensitization process that increase the animal response to harmless stimuli 
independently from the CS-US association) (Costanzi et, 2011). The main result of this 
study is that extinction when applied after retrieval of remote fear memory did not 
persistently attenuate the expression of fear. In a recent paper Pèrez-Cuesta (2009) 
investigated the effect of retrieval-extinction procedure in memory model of the crab 
Chasmagnathus (Maldonado, 2002). They trained crabs using the context-signal 
memory paradigm, and 24 hours later they exposed the crabs to the training context for 
15 minutes (short exposure induced retrieval of the conditioned context) and 15 minutes 
later they exposed the crabs to the same context for an additional 2 hours (long exposure 
induced extinction). The day after the crab were tested for CS-US memory (test 1), and, 
if no memory was found, the test was replicated 24 hours later (test 2) to distinguish 
reconsolidation impairment (supposed to be permanent) and extinction (supposed to be 
transient). On test 1 no memory recovery has been observed in crabs that receive the 
retrieval-extinction treatment, on the contrary on test 2 a re-emergence of memory have 
been noticed. These data suggest that extinction applied after retrieval does not update 
the original memory trace.  
The effect of the combination of retrieval and extinction has been also investigated 
using the paradigm of morphine-induced conditioned place preference (CPP) (Ma et al. 
2011). They showed that repeated retrieval-extinction procedure (across 10 days) 
suppressed the reinstatement and spontaneous recovery of extinguished CPP. On the 
other hand no effect was observed when extinction was applied without prior retrieval 
of the memory. However recovery of the CPP was found in a reinstatement test 
performed 4 week after the last extinction session. The latter finding suggests that 
memory trace was not been erased by post-retrieval extinction. It can be hypothesized 
that extinction applied after retrieval did not affect the reconsolidation of memory under 
the conditions used in the paper by Ma et al.; otherwise, as suggested by the authors, 
that reconsolidation blockade did not lead to the erasure of the memory that can re-
emerge by the passage of time.  
As far as concern the human studies, in 2011 Soeter & Kind pointed out that the 
electrodermal conditioning used by Schiller and colleagues seems to primarily reflect 
only the cognitive level (declarative memory) of contingency learning (CS-US 
association), whereas human strartle potentiation is considered to be a reliable and 
specific index of fear. In a within-subject (Soeter & Kindt, 2011) and in a between-
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subject (Kindt & Soeter in press) studies they tested whether extinction provided during 
the reconsolidation window prevents the return of the extinguished startle fear response, 
using a fear conditioning design. ) They found that extinction, provided after retrieval, 
doesn’t affect the startle fear response, skin conductance and US expectancy rating. The 
Schiller et al study and Soeter-Kindt study diverged in several ways, with most notable 
differences being the assessment of conditioned responding, i.e. single method (only 
skin conductance response) vs. multi-method of indexing fear (fear potentiated startle, 
skin conductance response, US expectancy rating, subjective assessment). The second 
difference between the two studies consisted in the conditioned stimuli used (geometric 
figures vs. fear-relevant pictures). 
 
1.4 Aim 
This research originated from the experimental evidences that drug related memories 
reconsolidation could be disrupted, and this could be fundamental in preventing the 
relapse to drug seeking behaviour. 
The aim of this research is to investigate if it is possible to disrupt nicotine memory 
reconsolidation by the application of extinction after retrieval of nicotine-related 
memory and whether this disruption prevent the relapse to nicotine-seeking behaviour 
in a rat model of nicotine dependence.  
Two main issues are addressed:  
1. Is a post-retrieval pharmacological treatment, such as propranolol or MK-801 
able to prevent the renewal of food or nicotine-seeking behaviour?  
2. Is it possible to disrupt food or nicotine memory reconsolidation by applying 
post-retrieval extinction of CS (i.e. a cue light) (CS-extinction) previously 
associated to food or nicotine self-administration (S/A) in rats? 
 We assessed whether post-retrieval administration of propranolol or MK-801 or 
extinction, applied in a context (CxB) different from that where food or nicotine S/A 
and CS association took place (CxA), may reduce renewal of nicotine-seeking 
behaviour when rats were placed back in CxA. Retrieval consists in presentation of the 
stimulus (CS, i.e. a light) previously paired with nicotine administration. Since the 
number of CS presentations at retrieval is a fundamental determinant of whether 
reconsolidation or extinction occurs (Tronson &Taylor, 2007), we also tested different 
length of retrieval (i.e. 1, 3, 30 and 300 CS presentations). 
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We performed five experiments: 
In Experiment #1 we assessed the effect of CS-extinction on renewal of nicotine-
seeking behaviour in rats trained to nicotine S/A. Retrieval consisted in 30 CS 
presentations. 
In Experiment #2 we assessed the effect of propranolol or CS-extinction on renewal of 
food seeking behaviour in rats trained to food S/A. Retrieval consisted in 30 CS 
presentations. 
In Experiment #3 we assessed the effect of propranolol or CS-extinction on renewal of 
nicotine seeking behaviour in rats trained to nicotine S/A. Retrieval consisted in 1 CS 
presentations. 
In Experiment #4 we assessed the effect of three different retrieval lengths (3, 30 or 300 
CS presentation) on renewal of nicotine seeking behaviour in rats trained to nicotine 
S/A. 
In Experiment #5 we assessed the effect of MK801 or CS-extinction on renewal of 
nicotine seeking behaviour in rats trained to nicotine S/A. Retrieval consisted in 3 CS 
presentations 
 
In the study-protocol we included no-retrieved groups and no-treated groups 
(receiving just a saline injection after retrieval or no-retrieval), these groups allow to 
control for the specificity of the treatment (propranolol, MK801 or extinction) effect 
on food or nicotine Pavlovian memories. 
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 EXP #1 EXP #2 EXP #3 EXP #4 EXP #5 
EXPERIMENTAL 
PARADIGM S/A 
Nicotine Food Nicotine Nicotine Nicotine 
RETRIEVAL 
LENGHT 
30 CS 
presentations 
30 CS 
presentations 
1 CS 
presentation 
3, 30 0r 300 CS 
presentations 
3 CS 
presentations 
TREATMENTS CS-extinction 
CS-extinction 
Propranolol 
CS-extinction 
Propranolol 
_ 
CS-extinction 
MK-801 
Figure 6: Schematic table of the experiments. In the Experiment #1 we assessed the 
effect of CS-extinction applied after 30 CS presentations on renewal of nicotine seeking 
behaviour. In Experiment #2 we assessed the effect of propranolol or CS-extinction 
applied after 30 CS presentations on renewal of food-seeking behaviour. Experiment #3 
we assessed the effect of propranolol or CS-extinction applied after 1 CS presentation 
on renewal of nicotine-seeking behaviour. Experiment #4 we assessed the effect of 
different retrieval length on renewal of nicotine-seeking behaviour. Experiment #5 we 
assessed the effect of MK-801 or CS-extinction applied contingently upon 3 CS 
presentations on renewal of nicotine-seeking behaviour 
 
1.4.1 Experimental model 
The experimental models used are food or intravenous nicotine S/A in rats, a paradigm 
based on operant and Pavlovian conditioning to food or nicotine and food- or nicotine-
associated cues. The term operant conditioning describes one type of associative 
learning in which there is a contingency between behaviour and the presentation of a 
biologically significant event (e.g. reinforcer). A positive reinforcement occurs when a 
behaviour (lever press) is followed by a stimulus which is appetitive or rewarding (e.g. 
food or nicotine administration), increasing the frequency of that behaviour 
(conditioned response). The term Pavlovian conditioning describe the associative 
learning in which an initially neutral stimulus (e.g. a light) repeatedly paired with an 
unconditioned stimulus (e.g food or nicotine administration-US) become associated to 
unconditioned stimulus and acquired a conditioned values (CS) which may elicit the 
conditioned response (e.g. food or nicotine seeking behaviour) even in the absence of 
US. 
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Addiction cannot be modelled in animals, at least a whole, however different 
procedures of operant behaviour can be applied as rodent analogues of addiction’s 
major elements including drug seeking and relapse (Ator and Griffiths, 2003; Sanchis-
Segura & Spanagel, 2006). Drug S/A has been widely characterized for all the drugs 
abused by humans, under different modes of administration. The paradigm has a high 
analogy to the pathological condition; it allows studying of the underlying 
neurobiological mechanisms, as well as having a high predictive validity for the 
identification of novel anti-addiction therapies. In our food or nicotine S/A models rats 
are placed in a cage, the so-called Skinner box (Figure 7), equipped with two levers, one 
active and one inactive.  
 
 
Figure 7: Skinner box photo. The operant chamber is placed in a sound and light-
isolating box. It is equipped with two levers (one active and one inactive) a catheter 
connected to a syringe pump (for nicotine injection) and with a sugar pellet magazine 
through which sugar pellet are delivered. 
 
 
Initially rats press the lever by chance. The pressing of active lever results in the 
administration of sugar pellet or nicotine infusion (rats are previously implanted with 
an intrajugular catheter) and in 5 seconds presentation of a cue light (CS). Since the 
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sugar pellet or nicotine act as reinforcement, the lever presses behaviour are repeated 
and become motivated to seek for food or nicotine infusion (conditioned response). 
Generally this training phase lasts until rats reach a stable response over at least three 
consecutive days. Since we are interested in investigating the Pavlovian memories, our 
criterion is a certain number of CS-US associations across the entire training phase 
(200±15) in order to have similar memory strength across each experimental group. 
Once trained the food or nicotine related memories are retrieved by the non-contingent 
presentation of CS. We chose to apply the retrieval and post-retrieval treatment in a 
context other then the training one in order to mimic human real life situation, in 
which smoking cessation treatment is generally applied in a context (e.g., hospital) 
other then the context where drug administration occurs. Manipulation such as 
propranolol, MK801 or CS-extinction is then provided within the reconsolidation 
window. It has been reported that one hour after retrieval, memory is labile and 
susceptible to disruption or updating (Monfils et al, 2009). Extinction consists is 
repeated presentation of CS contingently upon lever presses in the absence of food or 
nicotine delivery. This phase lasts until the behaviour has been extinguished (no lever 
presses for at least 30 minutes). Twenty-four hour later the effect of post-retrieval 
treatment (i.e. propranolol or MK801 or CS-extinction) on food or nicotine related 
memory are tested by measuring the conditioned response (number of lever presses) 
when the animals are placed in the context previously associated to food or nicotine 
administration (renewal) and are presented with the CS. 
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2. MATERIALS AND METHODS 
2.1.Subjects. 
Male Sprague Dawley rats (Harlan, Italy) were individually housed in a temperature-
controlled environment (19-23 °C) on a 12 hours light–dark cycle with light on at 06:30 
p.m. All the experimental procedures were conducted within the dark phase of the light-
dark circle. Animals were food restricted to maintain their body weight range between 
240-260 g. Food diet (2-4 pellets, for a total of 10-20 g/day) was made available after 
each experimental session. Animals have ad libitum access to water except during 
experimental sessions (3 to max 360 minutes/day). Rats were trained or tested once 
daily. All animal procedures were carried out in accordance with the Principles of 
laboratory animal care (National Institute of Health publication No.85/23, revised 
1985), the European Communities Council Directive of 24 November 1986 
(86/609/EEC). The inter-departmental Centre has approved these procedures for 
Laboratory Animal Service and Research of the Verona University, according to art.7 
D.L. 116/92 of the Italian Legislation. All efforts were made to minimize animal 
suffering and to keep the number of animals used as low as possible. 
 
2.2. Drugs. 
Nicotine hydrogen tartrate (Sigma, Italy) was dissolved in heparinised bacteriostatic 
saline (0.9% NaCl + 0.9% benzylalcohol + 1 IU/mL heparin) and pH adjusted to 7.4 
with NaOH Nicotine unit doses are expressed as mg of free base/kg of body 
weight/infusion. Adjustment of nicotine concentration to changes in rat body weight 
was not needed because rats’ body weight was kept stable at 250 g (± 10g). Propranolol 
hydrocloride (Sigma-Aldrich) was dissolved in saline (0.9% NaCl), while (+)-MK801 
hydrogen maleate (Sigma-Aldrich) was dissolved is ultrapure water (Milli-Q). Both 
propranolol and MK801 were administered via intraperitoneal injection (IP) in a volume 
of 1 mL/kg, immediately after retrieval (or no-retrieval session), or 30 minutes before 
the retrieval (or no-retrieval) session respectively. All doses were expressed as salt. 
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2.3 Experiment #1. 
2.3.1 Apparatus 
This experiment was conducted in eight identical operant conditioning chambers 
(Coulbourn Instruments, Lehigh Valley, Whitehall, PA, USA) encased in sound-
insulated cubicles, equipped with ventilation fans (Ugo Basile, Comerio, Italy). Each 
chamber was equipped with tow levers, symmetrically centred on the frontal panel, and 
located 12.5 cm apart, 2 cm above the grid floor. The food magazine was situated in an 
opening in a panel between the two levers, 1 cm above the floor. This opening was 
closed during nicotine S/A training, retrieval, CS-Extinction and renewal sessions. A 2 
W white house light was located 26 cm above the food magazine and activated during 
the entire session duration, except during the TO (60 seconds interval after each 
reinforcement in which levers are inactive). Right lever presses (nicotine paired lever-
NPL) corresponding to FR values, required the schedule of reinforcement, produced the 
delivery of 45-mg sugar food pellet (Bioser, USA) or the activation of the infusion 
pump (model A-99Z, Razel Scientific Instruments Inc., Stamford, CT, USA), except 
during the retrieval, CS-extinction and renewal sessions. Nicotine solution was 
administered via the infusion pump at the volume of 0.04638 mL during a 1-s period. 
Nicotine infusion was associated with 1second illumination of one yellow and one 
green light emitting diode (LED) centrally placed above the food magazine. Left lever 
presses (‘inactive lever presses’) did not have any consequence. All types of lever 
presses, sugar pellet and infusion deliveries were recorded. Data acquisition and 
schedule parameters were controlled by med-PC software (Med Associates Inc, 
Georgia, USA) running on a PC-computer interfaced with the chambers via interface 
modules (Med Associates Inc.). 
 
2.3.2. Training to lever press 
Following a 24-h food deprivation period, all rats were trained to lever press for food as 
reinforcement. The final training schedule of reinforcement was FR2. Session duration 
was 60 minutes. Once training to lever press for food reinforcement (it required 
approximately 2 weeks), rats underwent surgery to implant an i.v. cannula. 
 
2.3.3. Surgical procedure 
Rats were anaesthetized with 0.5 mg/kg/0.5 mL medetomidine (Domitor®, Pfizer, 
Italy), 10 mg/kg tiletamine + 10 mg/kg zolazepam (Zoletil 100®, Virbac, Italy; 0.2 
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mL/kg intramuscular), and then implanted with a Silicon catheter (inner diameter 0.30 
mm, outer diameter 0.63 mm, Cam Caths, Cambridgeshire, UK) in the right jugular 
vein. Immediately after surgery, animals were medicated with 5mg/kg/1 mL 
subcutaneous carprofen (Rymadyl®, Pfizer, Italy) and 25,000,000 IU benzylpenicilline 
+ 1 g/kg dihydrostreptomycin (Rubrocillina Forte®, Intervet, Italy; 1 mL/kg 
subcutaneous), 0.5 mg/kg/0.1 mL intramuscular atipamezole (Antisedan®, Pfizer, 
Italy). Each day after recovery, animals received 0.1 mL of one i.v. injection of heparin 
solution (30 IU/mL heparin sodium, Sigma, Italy) before and after the experimental 
session. 
 
2.3.4. Training to nicotine self-administration (S/A) 
After 7 days of recovery, rats were trained to intravenously self-administer nicotine. 
Initially the schedule of reinforcement was FR1: nicotine 0.03 mg/kg/infusion, 1 second 
CS, TO 60 seconds; session duration up to 25 infusions or 180 minutes elapsed. If the 
animals met the criterion of 25 infusions within the end of daily session, the FR value 
was increased to FR 2 with session duration lasting up to 60 minutes. . Rats were 
considered to reach a stable responding on nicotine S/A under a FR 2 schedule of 
reinforcement when the value of reinforcements/session did not vary more than 20% 
between three consecutive sessions. Lever pressing during the TO period was also 
recorded, although it did not have any consequence.  
 
2.3.5 Retrieval 
After the food S/A phase, rats were divided into two groups respectively exposed to 
retrieval (Ret) or not (No-Ret). Both groups were placed for 20 minutes in a novel 
context (CxB; Skinner box with thick blank striped sheets on the wall and a 1 cm grid 
on the floor). The Ret, but not the No-Ret, group was exposed to 30 non-contingent CS 
presentations (30[FI 40 s: 1 second CS]).  
 
2.3.6 Treatment 
After retrieval phase both groups were then returned to the home cage. One hour later 
all subjects t were moved in the CxB and underwent a CS-extinction session in which 
the schedule was FR2: 1 second CS. There was no nicotine delivery as consequence of 
NPL presses. Session duration lasted up to extinction of responding on NPL (no NPL 
presses for 30 minutes), or after 6 hours elapsed.  
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2.3.7 Renewal 
The day after the retrieval and the post-retrieval CS-extinction, all the subjects were re-
exposed to CxA (the context previously associated to nicotine S/A), and CS 
presentation was made contingent upon responding on FPL (renewal session): FR1: 1 
second CS, no nicotine, session duration 180 minutes. 
 
2.4 Experiment #2  
2.4.1 Apparatus 
Behavioural testing was conducted in operant chambers encased in sound-insulated 
cubicles, equipped with ventilation fans (Med Associates Inc., St Albans, Vermont, 
USA). Each chamber was equipped with 2 levers, symmetrically centred on the front 
panel. A 2 W house light was located on the back panel near the chamber ceiling to 
provide ambient illumination during the entire session duration, except during Time-Out 
(TO) periods and retrieval session. A fixed number (fixed-ratio-FR) of right lever (food 
paired lever-FPL) presses produced 1-second illumination stimulus light (CS) placed 
above the FPL and the delivery of 45 mg sugar food pellet (Bilaney Consultants Ltd., 
UK) except during CS-extinction and renewal sessions and CS-extinction. During the 
retrieval session, levers were not available and CS was presented on a Fixed-Interval 
(FI) 60 seconds time schedule. Left lever presses (inactive lever presses-ILP) did not 
have any consequence. All types of lever presses and sugar pellet deliveries were 
recorded. Data acquisition and schedule parameters were controlled by  Med-PC 
software (Med Associates Inc.).  
 
2.4.2. Training to lever press 
Following a 24 hours food deprivation period, all rats were trained to lever press for 
food as reinforcement. The final training schedule of reinforcement was FR2. Session 
duration was 60 minutes.  
 
2.4.3. Training to food self-administration (S/A) 
Rats were then trained to slightly different FR2 schedule of reinforcement in which two 
FPL presses resulted in the delivery of 45 mg sugar pellet and also in 1-second CS 
presentation. After sugar pellet delivery a TO period of 60 seconds starts during which 
each lever presses was recorded but had no consequences. Session lasts up to 25 
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reinforcements or 30 minutes. This training phase lasted up to 17 sessions in order to 
have duration comparable to that of nicotine self-administration training phase. 
 
2.4.4 Retrieval 
After the food S/A phase, rats were divided into two groups respectively exposed to 
retrieval (Ret) or not (No-Ret). On the retrieval session, both groups were placed for 20 
minutes in a novel context (CxB; Skinner box with thick blank striped sheets on the 
wall and a 1 cm grid on the floor). The Ret, but not the No-Ret, group was exposed to 
30 non-contingent CS presentations (30[FI 40 s: 1 second CS]). Both groups were 
further divided into three sub-groups, respectively treated with propranolol (Prop) or 
saline (Veh) or exposed to CS-extinction (CS-Ext). 
 
2.4.5 Treatment 
Immediately after the retrieval phase Ret/Prop and No-Ret/Prop groups received an IP 
injection of propranolol 10 mg/Kg, while Ret/Veh and No-Ret/Veh groups received an 
IP injection of saline. After retrieval phase Ret/CS-Ext and No-Ret/CS-Ext groups were 
placed back in their home cage for 1 hour, then they were moved in the CxB and 
underwent a CS-extinction session in which the schedule was FR2: 1 second CS. There 
was no food delivery as consequence of FPL presses. Session duration lasted up to 
extinction of responding on FPL (no FPL presses for 30 minutes), or after 6 hours 
elapsed.  
 
2.4.6 Renewal 
The day after the retrieval and the post-retrieval treatment, all the subjects were re-
exposed to CxA (the context previously associated to food S/A), and CS presentation 
was made contingent upon responding on FPL (FR1: 1 second CS, no sugar pellet). 
Session duration was 180 minutes. 
 
2.5. Experiment #3. 
2.5.1 Apparatus 
Behavioural testing was conducted in operant chambers encased in sound-insulated 
cubicles, equipped with ventilation fans (Med Associates Inc., St Albans, Vermont, 
USA). Each chamber was equipped with 2 levers, symmetrically centred on the front 
panel. A 2 W house light was located on the back panel near the chamber ceiling to 
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provide ambient illumination during the entire session duration, except during Time-Out 
(TO) periods and retrieval session. A fixed number (fixed-ratio-FR) of right lever 
(nicotine paired lever-NPL) presses produced 1 second illumination of a stimulus light 
(CS) placed above the FPL, and the delivery of 45 mg sugar food pellet (Bilaney 
Consultants Ltd., UK) or the activation of the infusion pump (Med Associates Inc.) 
except during CS-extinction and renewal sessions. During the retrieval session, levers 
were not available and CS was presented on a Fixed-Interval (FI) 60 seconds time 
schedule. Left lever presses (inactive lever presses-ILP) did not have any consequence. 
All types of lever presses and sugar food pellet deliveries were recorded. Data 
acquisition and schedule parameters were controlled by Med-PC software (Med 
Associates Inc.).  
 
2.5.2. Training to lever press 
Following a 24 hours food deprivation period, all rats were trained to lever press for 
food as reinforcement. The final training schedule of reinforcement was FR2. Session 
duration was 60 minutes. Once training to lever press for food reinforcement (it 
required approximately 2 weeks), rats underwent surgery to implant an i.v. cannula. 
 
2.5.3. Surgical procedure 
Rats were anaesthetized with 0.5 mg/kg/0.5 mL medetomidine (Domitor®, Pfizer, 
Italy), 10 mg/kg tiletamine + 10 mg/kg zolazepam (Zoletil 100®, Virbac, Italy; 0.2 
mL/kg intramuscular), and then implanted with a Silicon catheter (inner diameter 0.30 
mm, outer diameter 0.63 mm, Cam Caths, Cambridgeshire, UK) in the right jugular 
vein. Immediately after surgery, animals were medicated with 5mg/kg/1 mL 
subcutaneous carprofen (Rymadyl®, Pfizer, Italy) and 25,000,000 IU benzylpenicilline 
+ 1 g/kg dihydrostreptomycin (Rubrocillina Forte®, Intervet, Italy; 1 mL/kg 
subcutaneous), 0.5 mg/kg/0.1 mL intramuscular atipamezole (Antisedan®, Pfizer, 
Italy). Each day after recovery, animals received 0.1 mL of one i.v. injection of heparin 
solution (30 IU/mL heparin sodium, Sigma, Italy) before and after the experimental 
session. 
 
2.5.4. Training to nicotine self-administration (S/A) 
After 7 days of recovery, rats were trained to intravenously self-administer nicotine. 
Initially the schedule of reinforcement was FR1: nicotine 0.03 mg/kg/infusion, 1 second 
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CS, TO 60 seconds; session duration up to 25 infusions or 180 minutes elapsed. If the 
animals met the criterion of 25 infusions within the end of daily session, the FR value 
was increased to FR 2 with session duration lasting up to 60 minutes. . Rats were 
considered to reach a stable responding on nicotine S/A under a FR 2 schedule of 
reinforcement when the value of reinforcements/session did not vary more than 20% 
between three consecutive sessions. Lever pressing during the TO period was also 
recorded, although it did not have any consequence. 
 
2.5.5 Retrieval 
After the nicotine S/A phase, rats were divided into two groups respectively exposed to 
retrieval (Ret) or not (No-Ret). On the retrieval session, both groups were placed for 11 
seconds in a novel context (CxB; Skinner box with thick blank striped sheets on the 
wall and a 1 cm grid on the floor). The Ret, but not the No-Ret, group was exposed to 1 
non-contingent CS presentation. Both groups were further divided into three sub-
groups, respectively treated with propranolol (Prop) or saline (Veh) or exposed to CS-
extinction (CS-Ext). 
 
2.5.6 Treatment 
Immediately after the retrieval phase Ret/Prop and No-Ret/Prop groups received an IP 
injection of propranolol 10 mg/Kg; while Ret/Veh and No-Ret/Veh groups received an 
IP injection of saline.  After retrieval phase Ret/CS-Ext and No-Ret/CS-Ext groups were 
placed back in their home cage for 1 hour, then they were moved in the CxB and 
underwent a CS-extinction session in which the schedule was FR2: 1 second CS. There 
was no nicotine delivery as consequence of NPL presses. Session duration lasted up to 
extinction of responding on NPL (no NPL presses for 30 minutes), or after 6 hours 
elapsed.  
 
2.5.7 Renewal 
The day after the retrieval and the post-retrieval treatment, all the subjects were re-
exposed to CxA (the context previously associated to nicotine S/A), and CS 
presentation was made contingent upon responding on NPL (renewal session): FR1: 1 
second CS, no sugar pellet, session duration 180 minutes. 
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2.6 Experiment #4. 
2.6.1 Apparatus 
Behavioural testing was conducted in operant chambers encased in sound-insulated 
cubicles, equipped with ventilation fans (Med Associates Inc., St Albans, Vermont, 
USA). Each chamber was equipped with 2 levers, symmetrically centred on the front 
panel. A 2 W house light was located on the back panel near the chamber ceiling to 
provide ambient illumination during the entire session duration, except during Time-Out 
(TO) periods and retrieval session. A fixed number (fixed-ratio-FR) of right lever 
(nicotine paired lever-NPL) presses produced the 1-second illumination of a stimulus 
light (CS) placed above the NPL, and delivery of 45 mg sugar food pellet (Bilaney 
Consultants Ltd., UK) or the activation of the infusion pump (Med Associates Inc.) 
except during CS-extinction and renewal sessions. During the retrieval session, levers 
were not available and CS was presented on a Fixed-Interval (FI) 60 seconds time 
schedule. Left lever presses (inactive lever presses-ILP) did not have any consequence. 
All types of lever presses and sugar food pellet deliveries were recorded. Data 
acquisition and schedule parameters were controlled by aMed-PC software (Med 
Associates Inc.).  
 
2.6.2. Training to lever press 
Following a 24 hours food deprivation period, all rats were trained to lever press for 
food as reinforcement. The final training schedule of reinforcement was FR2. Session 
duration was 60 minutes. Once training to lever press for food reinforcement (it 
required approximately 2 weeks), rats underwent surgery to implant an i.v. cannula. 
 
2.6.3. Surgical procedure 
Rats were anaesthetized with 0.5 mg/kg/0.5 mL medetomidine (Domitor®, Pfizer, 
Italy), 10 mg/kg tiletamine + 10 mg/kg zolazepam (Zoletil 100®, Virbac, Italy; 0.2 
mL/kg intramuscular), and then implanted with a Silicon catheter (inner diameter 0.30 
mm, outer diameter 0.63 mm, Cam Caths, Cambridgeshire, UK) in the right jugular 
vein. Immediately after surgery, animals were medicated with 5mg/kg/1 mL 
subcutaneous carprofen (Rymadyl®, Pfizer, Italy) and 25,000,000 IU benzylpenicilline 
+ 1 g/kg dihydrostreptomycin (Rubrocillina Forte®, Intervet, Italy; 1 mL/kg 
subcutaneous), 0.5 mg/kg/0.1 mL intramuscular atipamezole (Antisedan®, Pfizer, 
Italy). Each day after recovery, animals received 0.1 mL of one i.v. injection of heparin 
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solution (30 IU/mL heparin sodium, Sigma, Italy) before and after the experimental 
session. 
 
2.6.4. Training to nicotine self-administration (S/A) 
After 7 days of recovery, rats were trained to intravenously self-administer nicotine 
under a schedule of reinforcement of FR1. NPL presses resulted in nicotine 0.03 
mg/kg/infusion, 5 seconds CS. Sixty seconds TO period was included. Session duration 
lasted up to 25 infusions or 60 minutes were elapsed. Lever pressing during the TO 
period was also recorded, although it did not have any consequence. Rats were 
considered to meet the criteria of nicotine S/A training once they reached the value of 
200 ± 15 (Standard Error of the Mean-S.E.M.) associations between nicotine infusion 
and CS (i.e., total number of nicotine reinforcement/CS associations = 200).  
 
2.6.5. Instrumental learning extinction phase (ILEXT) 
Following the nicotine S/A phase, NPL responding was extinguished during an 
instrumental learning extinction phase. On these daily 60 min sessions, subjects were 
placed in the operant chamber and responding on either lever had no programmed 
consequences. Instrumental learning extinction criterion was reached when NPL 
presses/session were < 50% of NPL at the first instrumental learning extinction session, 
for at least three consecutive sessions (Chiamulera et al., 2010). The inclusion in the 
study protocol design of an instrumental learning extinction phase allowed to control for 
the operant conditioning component of nicotine S/A, and to evaluate the specificity of 
the CS- extinction effect on nicotine Pavlovian conditioning. 
 
2.6.6 CS presentation 
After the ILEXT phase, rats were divided into four groups exposed to 3 (3CS), 30 
(30CS), 300 (300CS) or 0 (0CS) presentations respectively. All groups (3CS, 30CS, 
300CS and 0CS) were placed in a novel context CxB; Skinner box with thick blank 
striped sheets on the wall and a 1 cm grid on the floor) for 3, 30, 30, 300 and 60 minutes 
respectively, and exposed to 3, 30, 300 or 0 CS presentation respectively (3, 30 or 300 
[FI 55 seconds: 5-seconds CS]).  
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2.6.7 Renewal 
The day after the CS presentation session, all the subjects were re-exposed to CxA (the 
context previously associated to nicotine Self-Administration), and CS presentation was 
made contingent upon responding on NPL (renewal session): FR1: 5-seconds CS, no 
nicotine infusion, session duration 180 minutes. 
 
2.7. Experiment #5. 
2.7.1 Apparatus 
Behavioural testing was conducted in operant chambers encased in sound-insulated 
cubicles, equipped with ventilation fans (Med Associates Inc., St Albans, Vermont, 
USA). Each chamber was equipped with 2 levers, symmetrically centred on the front 
panel. A 2 W house light was located on the back panel near the chamber ceiling to 
provide ambient illumination during the entire session duration, except during Time-Out 
(TO) periods and retrieval session. A fixed number (fixed-ratio-FR) of right lever 
(nicotine paired lever-NPL) presses produced the 1-second illumination of a stimulus 
light (CS) placed above the NPL, and delivery of 45 mg sugar food pellet (Bilaney 
Consultants Ltd., UK) or the activation of the infusion pump (Med Associates Inc.) 
except during CS-extinction and renewal sessions. During the retrieval session, levers 
were not available and CS was presented on a Fixed-Interval (FI) 60 seconds time 
schedule. Left lever presses (inactive lever presses-ILP) did not have any consequence. 
All types of lever presses and sugar food pellet deliveries were recorded. Data 
acquisition and schedule parameters were controlled by a Med-PC software (Med 
Associates Inc.).  
 
2.7.2. Training to lever press 
Following a 24-h food deprivation period, all rats were trained to lever press for food as 
reinforcement. The final training schedule of reinforcement was FR2. Session duration 
was 60 minutes. Once training to lever press for food reinforcement (it required 
approximately 2 weeks), rats underwent surgery to implant an i.v. cannula. 
 
2.7.3. Surgical procedure 
Rats were anaesthetized with 0.5 mg/kg/0.5 mL medetomidine (Domitor®, Pfizer, 
Italy), 10 mg/kg tiletamine + 10 mg/kg zolazepam (Zoletil 100®, Virbac, Italy; 0.2 
mL/kg intramuscular), and then implanted with a Silicon catheter (inner diameter 0.30 
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mm, outer diameter 0.63 mm, Cam Caths, Cambridgeshire, UK) in the right jugular 
vein. Immediately after surgery, animals were medicated with 5mg/kg/1 mL 
subcutaneous carprofen (Rymadyl®, Pfizer, Italy) and 25,000,000 IU benzylpenicilline 
+ 1 g/kg dihydrostreptomycin (Rubrocillina Forte®, Intervet, Italy; 1 mL/kg 
subcutaneous), 0.5 mg/kg/0.1 mL intramuscular atipamezole (Antisedan®, Pfizer, 
Italy). Each day after recovery, animals received 0.1 mL of one i.v. injection of heparin 
solution (30 IU/mL heparin sodium, Sigma, Italy) before and after the experimental 
session. 
 
2.7.4. Training to nicotine self-administration (S/A) 
After 7 days of recovery, rats were trained to intravenously self-administer nicotine 
under a schedule of reinforcemen of FR1. NPL presses resulted in nicotine 0.03 
mg/kg/infusion, 5 seconds CS presentation. Sixty seconds TO period was included. 
Session duration lasted up to 25 infusions or 60 minutes were elapsed. Lever pressing 
during the TO period was also recorded, although it did not have any consequence. Rats 
were considered to meet the criteria of nicotine S/A training once they reached the value 
of 200 ± 15 (S.E.M.) associations between nicotine infusion and CS (i.e., total number 
of nicotine reinforcement/CS associations = 200).  
 
2.7.5. Instrumental learning extinction phase (ILEXT) 
Following the nicotine S/A phase, NPL responding was extinguished during an 
instrumental learning extinction phase. On these daily 60 minutes sessions, subjects 
were placed in the operant chamber and responding on either lever had no programmed 
consequences. Instrumental learning extinction criterion was reached when NPL 
presses/session were < 50% of NPL at the first instrumental learning extinction session, 
for at least three consecutive sessions (Chiamulera et al., 2010). The inclusion in the 
study protocol design of an instrumental learning extinction phase allowed to control for 
the operant conditioning component of nicotine S/A, and to evaluate the specificity of 
the CS- extinction effect on nicotine Pavlovian conditioning. 
 
2.7.6 Retrieval 
After the ILEXT phase, rats were divided into two groups respectively exposed to 
retrieval (Ret) or not (No-Ret). On the retrieval session, both groups were placed for 3 
minutes in a novel context (CxB; Skinner box with thick blank striped sheets on the 
 44 
wall and a 1 cm grid on the floor). The Ret, but not the No-Ret, group was exposed to 3 
non-contingent CS presentation (3[FI 55 s: 5-second CS]). Both groups were further 
divided into three sub-groups, respectively treated with MK-801 (MK801) or saline 
(Veh) or exposed to CS-extinction (CS-Ext). 
 
2.7.7 Treatments 
Immediately after the retrieval phase Ret/MK801 and No-Ret/MK801 groups received 
an IP injection of MK-801 0.1 mg/Kg; while Ret/Veh and No-Ret/Veh groups received 
an IP injection of water Milli-Q.  After retrieval phase Ret/CS-Ext and No-Ret/CS-Ext 
groups were placed back in their home cage for 1 hour, then they were moved in the 
CxB and underwent a CS-extinction session in which the each NPL press resulted in 5 
seconds CS presentation. There was no nicotine delivery as consequence of NPL 
presses. Session duration lasted up to extinction of responding on NPL (no NPL presses 
for 30 minutes), or after 6 hours elapsed.  
 
2.7.8 Renewal 
The day after the retrieval and the post-retrieval treatment, all the subjects were re-
exposed to CxA (the context previously associated to nicotine Self-Administration), and 
CS presentation was made contingent upon responding on NPL (renewal session)(FR1: 
5-seconds CS). Session duration was 180 minutes. 
 
2.8 Data Analyses. 
NPL or FLP responding on renewal session was compared among groups in order to 
test the efficacy of treatments (propranolol, MK-801, CS-extinction, vehicle). First of 
all, a two factor ANOVA was performed on total NPL or FLP /180 minutes on renewal 
session for factor retrieval (two levels: Ret, No-Ret) and factor treatment (two to four 
levels; e.g.: propranolol, MK-801, CS-extinction, vehicle).  Since cumulative NPL or 
FPL were recorded at different time-points during the renewal session (at 15, 30, 45, 60, 
120 and 180 minutes during session duration), a series of two factor ANOVA were 
performed for factors time-point at different levels (15, 30, 45, 60, 120 and 180 
minutes), and treatment (two to four levels; e.g.: propranolol, MK-801, CS-extinction, 
vehicle). Each series of ANOVA was separately performed for Ret and No-Ret groups. 
Statistical analysis was performed by using Prism 4 (Graph Pad, U.S.A.). 
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3. RESULTS 
3.1. The Model 
3.1.1. Food self-administration acquisition. 
In Experiment #2 rats were trained to self-administer food. Seventy-eight out of eighty 
rats reached the criteria of food self-administration, the training lasts 16 ± 1 daily 
sessions (mean ± S.D.). The average numbers of food-paired lever (FPL) and inactive 
lever (IL) presses across last three sessions were 277.3 ± 9.4 and 27.5 ± 4.7 respectively 
(mean ± S.E.M.) (Figure 8, panel A). The specificity of food seeking behaviour by rats 
is confirmed by the discrimination between FPL and IL presses (Figure 8, panel A). 
Moreover in Figure 8, panel B the stability of the responding can be observed. 
 
 
Figure 8: Food self-administration acquisition. A) Mean number of food-paired lever 
(FPL) presses and inactive lever (IL) presses (± S.E.M.) across daily sessions are 
represented by solid and open squares respectively (n=78). Discrimination between FPL 
and IL can be observed across each session. B) Mean number of reinforcements (sugar 
pellet delivery) across daily session. All the animals reached the criteria of maximum 
number of reinforcement (25) at each session. (FPL: food paired lever; IL: inactive 
lever). 
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3.1.2 Nicotine self-administration acquisition 
In Experiment #1, #3, #4 and #5 rats were trained to self-administer nicotine. 
In Experiment #1 and #3 (see experimental design in Figure 16 and 23 respectively) 
were trained until the number of reinforcements/session did not vary more than 20% 
between three consecutive sessions (criteria of stability).  
In Experiment #1 eleven out of 20 rats reached the criteria of stability after the average 
number of 20.5 ± 1.4 (mean ± SEM) sessions. At stability, the average number of 
nicotine infusions was 17.8 ± 0.5 (mean ± SEM of the last three self-administration 
session) (Figure 9, panel B). The average number of nicotine-paired lever (NPL) and 
inactive lever (IL) presses across the last three sessions were 107,3 ± 12,7 and 13,2 ± 
1,8 respectively (mean ± SEM). The specificity of nicotine seeking behaviour is 
confirmed by the discrimination between NPL and IL (Figure 9, panel B). 
 
 
Figure 9: Nicotine self-administration acquisition in Experiment #1. A) Mean number 
of NPL and IL  (± S.E.M.) across daily sessions are represented by solid and open 
squares respectively (n=11). Discrimination between NPL and IL can be observed 
across each session. B) Mean number of reinforcement (nicotine infusion) across daily 
session. Stability of the response can be observed across last three sessions. (NPL: 
nicotine paired lever; IL: inactive lever). 
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In Experiment #3, 26 out of 32 rats reached the criteria of stability after the average 
number of 13.7 ± 0.3 (mean ± SEM) sessions. At stability, the average number of 
nicotine infusions was 14.1 ± 0.4 (mean ± SEM of the last three self-administration 
session) (Figure 10, panel B). The average number of NPL and IL presses across the last 
three sessions was 41.3 ± 0.9 and 11.9 ± 0.9 respectively (mean ± SEM). The 
discrimination between NPL and IL provides goal-directed evidence towards nicotine-
seeking behaviour (Figure 10, panel A). 
 
Figure 10: Nicotine self-administration acquisition in Experiment #3. A) Mean number 
of NPL and IL  (± S.E.M.) across daily sessions are represented by solid and open 
squares respectively (n=26). Discrimination between NPL and IL can be observed 
across each session B) Mean number of reinforcement (nicotine infusion) across daily 
session. Stability of the response can be observed across the last three sessions. (NPL: 
nicotine paired lever; IL: inactive lever). 
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In Experiments #4 and # 5 (For experimental design see Figure 27 and 30 respectively) 
rats were considered to meet the criteria of nicotine S/A training once they reached the 
value of 200 ± 15 (S.E.M.) associations between nicotine infusion and CS (i.e., total 
number of nicotine reinforcement/CS associations = 200).  
In Experiment #4 training to nicotine self administration lasted 13, 7 ± 0,5 daily session 
(mean ± S.E.M). All the rats met the criteria of total number of CS/nicotine 
reinforcement associations = 200 (± 15; S.E.M.) at the end of the nicotine self-
administration training phase: 190 ± 5,8, 209 ± 8,5, 195.2 ± 5.9 and 196.2 ± 8.1 total 
number of CS/nicotine reinforcement associations, respectively for 0CS, 3CS, 30CS, 
300CS groups (mean ± S.E.M.). Mean (± S.E.M.) number of NPL presses over the last 
three nicotine S/A sessions was 21.8 ± 2.6, 52.8 ± 13.4, 23.7 ± 2..4 and 30.6 ± 4.4 NPL 
presses/60 minutes session (4.5 ± 0.9, 10.6 ± 2.2, 6.6 ± 2.3 and 4.6 ± 2.7 IL presses/60 
min session), respectively for 0CS, 3CS, 30CS, 300CS groups. The discrimination 
between NPL and IL provides goal-directed evidence towards nicotine-seeking 
behaviour (Figure 11, panel A) 
 
 
Figure 11: Nicotine self-administration acquisition in Experiment #4. A) Mean number 
of NPL and IL  (± S.E.M.) across daily sessions are represented by solid and open 
squares respectively (n=16). Discrimination between NPL and IL can be observed 
across each session. B) Mean number of reinforcement (nicotine infusion) across daily 
session. (NPL: nicotine paired lever; IL: inactive lever). 
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In Experiment #5 training to nicotine self administration lasted 13. 4 ± 0.4 daily session 
(mean ± S.E.M). All the rats met the criterion of total number of CS/nicotine 
reinforcement associations = 200 ± 15 (mean ± S.E.M.) at the end of the nicotine self-
administration training phase: 203.9 ± 8.2, 205.7 ± 80, 200.5 ± 7.7 and 200.3 ± 5.9 total 
number of CS/nicotine reinforcement associations, respectively for Ret/Sal, Ret/CS-Ext, 
No-Ret/Sal, No-Ret/CS-Ext groups (mean ± S.E.M.). Mean (± S.E.M.) number of NPL 
presses over the last three nicotine self-administration sessions was 26.7 ± 2.6, 30.3 ± 
2,0, 31.6 ± 3.8 and 28.2 ± 2.8 NPL presses/60 minutes session (5.4 ± 0.9, 7.2 ± 1.1, 6.0 
± 0.9 and 6.8 ± 1.2 IL presses/60 min session), respectively for Ret/Sal, Ret/CS-Ext, 
No-Ret/Sal, No-Ret/CS-Ext groups. The discrimination between NPL and IL provides 
goal-directed evidence towards nicotine-seeking behaviour (Figure 12, panel A) 
 
 
Figure 12: Nicotine self-administration acquisition in Experiment #5. A) Mean number 
of NPL and IL  (± S.E.M.) across daily sessions are represented by solid and open 
squares respectively (n=88). Discrimination between NPL and IL can be observed 
across each session. B) Mean number of reinforcement (nicotine infusion) across daily 
session. Stability of the response can be observed across last three sessions. (NPL: 
nicotine paired lever; IL: inactive lever). 
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3.1.3 Instrumental learning extinction phase 
In experiments #4 and #5 rats underwent an instrumental learning extinction phase in 
order to extinguish the operant component of conditioning.  
In experiment #4 all the groups met the criteria of extinguished responding (less than 
50% of NPL presses at the first instrumental learning extinction phase session, for three 
consecutive session): 6.4 ± 0.4, 6.1 ± 0.8, 3.6 ± 0.7 and 6.2 ± 0.8 NPL presses/60 min 
session (3.3 ± 1.8, 3.2 ± 2.0, 1.6 ± 0.5 and 2.6 ± 1.5 inactive lever presses/60 min 
session) (mean ± S.E.M.) respectively for CS0, CS3, CS30 and CS groups (Figure 13). 
The criteria of instrumental learning extinction was met after an average number of 11 ± 
0,6 daily sessions (mean ± S.E.M.). 
 
 
Figure 13: Instrumental learning extinction in Experiment #4. Mean number of NPL and 
IL presses (± S.E.M.) across daily sessions are represented by black open solid and open 
squares respectively (n= 16). Across last three session the number of NPL presses were 
less than 50% of the number of NPL presses on the first session. (NPL: nicotine paired 
lever; IL: inactive lever). 
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In experiment #5 all the groups met the criteria of extinguished responding (less than 
50% of NPL presses at the first instrumental learning extinction phase session, for three 
consecutive session): 6.2 ± 0.8, 5.8 ± 0.6, 7.0 ± 0.6, 4.6 ± 0.5, 5.9 ± 0.8 and 6.0 ± 0.4 
NPL presses/60 min session (2.2 ± 0.6, 1.8 ± 0.3, 2.4 ± 0.4, 2.6 ± 0.5, 2.1 ± 0.3, 2.5 ± 
0.5 inactive lever presses/60 min session) (mean ± S.E.M.) respectively for Ret/Sal, 
Ret/CS-Ext, Ret/MK801, No-Ret/Veh, No-Ret/CS-Ext and No-Ret/MK801  groups 
(Figure 14). The criteria of instrumental learning extinction were met after an average 
number of 9,5±0,6 daily sessions (mean ± S.E.M.). 
 
Figure 14: Instrumental learning extinction in Experiment #5. Mean number of NPL and 
IL presses (± S.E.M.) across daily sessions are represented by solid and open squares 
respectively (n=88). Across last three sessions the number of NPL presses were less 
than 50% of the number of NPL presses on the first session. (NPL: nicotine paired 
lever; IL: inactive lever). 
 
3.1.4 Renewal  
Two days after the end of self-administration training (experiments #1,#2 and #3) or 
instrumental learning extinction phase (experiments #4 and #5), a renewal session was 
performed. In order to reinstate the nicotine seeking-behaviour, rats were placed back in 
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the context previously paired with nicotine administration and were exposed to 
conditioned stimuli.  Reinstatement of nicotine seeking behaviour is revealed by a 
significantly higher responding/lever presses on lever previously paired with nicotine 
compared (Figure 15, panel B) to the responding during the last Instrumental learning 
extinction session (Figure 15, panel A). 
 
 
Figure 15: Example of Renewal of nicotine-seeking behaviour (animal code: TOM21). 
Graphs represent number of NPL (ordinates) across minutes (abscissa) during the last 
instrumental learning extinction session (panel A) and renewal session (panel B). Each 
step represents a lever press. On renewal a reinstatement of nicotine seeking behaviour 
(lever presses) can be observed. 
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3.2. The Project 
3.2.1. Experiment #1 
 
Figure 16: Schematic diagram of experimental design in experiment #1. Rats were 
trained to nicotine self-administration (S/A)(approximately 20 sessions). One day after 
last S/A session, they were divided into two groups that underwent a retrieval or no-
retrieval session respectively in a context other then the S/A one (CX B). One hour after 
the end of retrieval (or no-retrieval) both groups (Ret/CS-Ext and No-Ret/CS-Ext) 
underwent a CS-extinction session in which CS, but not nicotine was presented upon 
NPL press. Session lasted until the extinction of response (no NPL presses for 30 
minutes) and took place in CX B. The day after memory was tested in a renewal session 
that consisted in placing the rats in the S/A training context (CX A) and during which 
each NPL press resulted in a CS presentation. 
 
  
The total NPL presses at the end of the 180 minutes renewal session was 113.0 ± 73.3, 
69.8 ± 51.7 (5.6 ± 5.4, 2.2 ± 1.8 ILP) (mean ± S.E.M.) respectively for Ret/CS-Ext (n = 
5), No-Ret/CS-Ext (n = 5) (Figure 17). There is no statistically significant difference in 
NPL between groups.   
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Figure 17: Renewal test in Experiment #1. Retrieval (30 CS presentation) had no effect 
on Cs-extinction in a renewal test (Experiment #1). Data are expressed as total number 
of nicotine-paired (NPL) lever presses at the end of renewal session (mean ± S.E.M.) 
for Ret/Cs-Ext group (open column, n=5) and No-Ret/Cs-Ext group (black column, 
n=6). No statistically significant difference between Ret/CS-Ext and No-Ret/CS-Ext 
groups. 
 
Temporal analyses of cumulative NPL responding during the renewal session were 
performed at different time-points (15, 30, 45, 60, 120, 180 minutes) (Figure 18). Two 
way ANOVA analyses for factor retrieval at two levels (Ret, No-Ret) and time-point at 
six levels (i.e., at 180, 120, 60, 45, 30, 15 min) showed statistically significant main 
effects of time-point (F[5,45] = 0.42; p <0.001) but not of retrieval (F[1,45] = 0.60 ; p = 
0.45) neither for the interaction between retrieval and time-point (F[5,45] = 0.91; p = 
0.29.).  
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Figure 18: Temporal analysis of renewal (Experiment #1). Data are expressed as 
number of NPL (mean ± S.E.M) at different time-points of the renewal session. A 
significant effect of time-point have been observed but not of retrieval (see text). 
 
 
In summary no difference between Ret/CS-Ext and NoRet/CS-Ext was observed on 
renewal test. At all time-points during the 180 minutes session, the two groups exhibited 
a significantly greater responding on NPL than on inactive lever (statistical analysis not 
shown).  
 
 56 
3.2.2. Experiment #2 
 
Figure 19: Schematic diagram of experimental design in experiment #2. Rats were 
trained to food self-administration (S/A) (approximately 16 sessions). One day after the 
end of S/A phase they were divided into two groups that underwent a retrieval or no-
retrieval session respectively, in a context other then the S/A training one (CX B). Then 
both Ret and No-Ret groups were divided into three subgroups. Ret/CS Ext and No-
Ret/CS-Ext, one hour after the end of retrieval, underwent a CS-Extinction session in 
which CS, but not food was presented upon FPL press. Session lasted until the 
extinction of response (no FPL presses for 30 minutes) and took place in CX B. 
Ret/Prop and No-Ret/Prop immediately after retrieval received a propranolol injection. 
Ret/Veh and No-Ret/Veh received a saline injection.  The day after, memory was tested 
in a renewal session that consisted in placing the rats in the S/A training context (CX A) 
and during which each FPL press resulted in a CS presentation.  
 
 
The total food paired lever (FPL) presses active lever presses at the end of the 180 
minutes renewal session was 196.8 ± 42.4, 85.8 ± 24, 183.4 ± 26.6, 246 ± 30.3 and 90.6 
± 19.1, 192.8 ± 17.7 (36.9 ± 10.6, 15.0 ± 4.9, 25.9 ± 5.1, 32.9 ± 5.9, 21.4 ± 5.5 and 30.0 
± 5.9 inactive lever presses) (mean ± S.E.M.) respectively for Ret/Veh (n = 14), Ret/CS-
Ext (n = 12), Ret/Prop (n= 10), No-Ret/Veh (n = 14), No-Ret/CS-Ext (n = 10), No-
Ret/Prop (n=9) groups (Figure 20). To compare the results of CS-extinction or 
propranolol vs. vehicle we run two separate two way ANOVA with factor retrieval (Ret, 
No-Ret) and factor treatment (CS-Ext or Prop and Veh). In the analysis comparing CS-
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Ext vs. Veh two way ANOVA showed no significant main effect for factors retrieval 
(Ret, No-Ret) (F[1,27] = 0.87 ; p = 0.35) neither for the interaction between retrieval and 
treatment (CS-Ext, Veh,) (F[2,27] = 0.59; p = 0.59) but a significant main effect of 
treatment (F[1,27] = 16.77; p <0.001). Bonferroni post-hoc test revealed a statistically 
significant difference between Ret/Veh and Ret/CS-Ext (p<0.05), and between No-
Ret/Veh and No-Ret/CS-Ext (p<0.01) (Figure 20). In the analysis comparing Prop vs. 
Veh two way ANOVA showed no significant main effect for factors retrieval (Ret, No-
Ret) (F[1,23] = 0.84 ; p = 0.36), neither for factor treatment (F[1,23] = 0.80; p = 0.38), or 
for the interaction between retrieval and treatment (F[1,23] = 0.39; p = 0.54).  
 
 
Figure 20: Renewal test in Experiment #2. Total number of food-paired (FPL) lever 
presses at the end of renewal session in Experiment #2. Data are expressed as mean 
number of FPL presses ± S.E.M. CS-extinction decreased the renewal of food seeking 
behaviour (FPL presses) both after retrieval or no-retrieval (Ret/Veh n=14; Ret/CS-Ext 
n=12; Ret/Prop n=10; No-Ret/Veh n=13; No-Ret/CS-Ext 10; No-Ret/Prop n=9). *= p< 
0.05 Ret/CS-Ext vs. Ret/Sal (Bonferroni post-hoc test) ; **= p< 0.01 No-Ret/CS-Ext vs. 
No-Ret/Sal (Bonferroni post-hoc test ). 
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Temporal analyses of cumulative active lever responding during the renewal session 
were performed at different time-points (15, 30, 45, 60, 120, 180 minutes) separately for 
each Ret and No-Ret groups. For Ret groups (Figure 21), two way ANOVA analyses 
for factor treatment at two levels (CS-Ext, Veh,) and time-point at six levels (i.e., at 
180, 120, 60, 45, 30, 15 minutes) showed statistically significant main effects of both 
time-point (F[1,120] = 31,72; p < 0.0001)  and treatment (F[1,120] = 8.27; p = 0.008). 
Moreover significant effect for interaction between factors was observed (F[5,120] = 
11.21; p < 0.0001). Bonferroni post-hoc test did not show any significant difference 
between groups. For Ret groups (Figure 21), two way ANOVA analyses for factor 
treatment at two levels (Prop, Veh,) and time-point at six levels (i.e., at 180, 120, 60, 45, 
30, 15 minutes) showed statistically significant main effects of time-point (F[1,110] = 
46.38; p < 0.0001) but not for treatment (F[1,110] = 0.23; p = 0.63), neither for interaction 
between factors was observed (F[5,110] = 0.64; p = 0.67). Bonferroni post-hoc test did not 
show any significant difference between groups. (Figure 21). 
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Figure 21: Temporal analysis of renewal for Ret groups in Experiment #2. Data are 
expressed as number of FPL (mean ± S.E.M) at different time-points of the renewal 
session. Two way ANOVA have revealed a main effect of CS-extinction but not of 
propranolol (see text).  Bonferroni post-hoc analyses did not show any differences 
between groups. 
 
 
For No-Ret group (Figure 22) Two way ANOVA analyses for factor treatment at two 
levels (CS-Ext, Veh) and time-point (i.e., at 180, 120, 60, 45, 30, 15 min) showed 
statistically significant main effects of both time-point (F[5,105] = 30.67; p < 0.0001) and 
treatment (F[1,105] = 13.06; p = 0.002). Moreover significant effect for interaction 
between factors was observed (F[5,105] = 12.34; p < 0.001). Bonferroni post-hoc test did 
not show any significant difference between groups. Two way ANOVA analyses for 
factor treatment at two levels (Veh, Prop) and time-point (i.e., at 180, 120, 60, 45, 30, 
15 minutes) showed statistically significant main effects of time-point (F[5,100] = 44.97; p 
< 0.0001)but not for treatment (F[1,100] = 0.84; p = 0.37)neither for interaction between 
factors was observed (F[5,100] = 2.30; p = 0.05). Bonferroni post-hoc test did not show 
any significant difference between groups.  
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Figure 22: Temporal analysis of renewal for No-Ret groups in Experiment #2. Data are 
expressed as number of FPL (mean ± S.E.M) at different time-points of the renewal 
session. Two way ANOVA have revealed a main effect of CS-extinction but not of 
propranolol (see text).  Bonferroni post-hoc analyses did not show any differences 
between groups. 
 
 
In summary in the analysis taking in consideration the retrieved group (Ret/Veh and 
Ret/CS-Ext), as well as in the analysis taking in consideration the no-retrieved group 
(No-Ret/Veh and No-Ret/CS-Ext), two way ANOVA for factor time point and factor 
treatment (CS-extinction, vehicle) showed a main effect of treatment. No effect of 
propranolol was observed across either in retrieved and in no-retrieved groups 
(Ret/Veh, Ret/Prop or No-Ret/Veh, No-Ret/Prop). 
At all time-points during the 180 min session, the six groups exhibited a significantly 
greater responding on active lever than on inactive lever (statistical analysis not shown).  
 
 
 
 
61 
3.2.3 Experiment #3 
 
Figure 23: Schematic diagram of experimental design in experiment #3. Rats were 
trained to nicotine self-administration (S/A) (approximately 14 sessions). One day after 
the end the S/A phase, rats were divided into two groups that underwent a retrieval or 
no-retrieval session respectively, in a context other then the S/A training one (CX B). 
Then both Ret and No-Ret groups were divided into three subgroups. Ret/CS Ext and 
No-Ret/CS-Ext, one hour after the end of retrieval, underwent a CS-Extinction session 
in which CS, but not nicotine was presented upon NPL press. Session lasted until the 
extinction of response (no NPL presses for 30 minutes) and took place in CX B. 
Ret/Prop and No-Ret/Prop immediately after retrieval received a propranolol injection. 
Ret/Veh and No-Ret/Veh received a saline injection.  The day after memory was tested 
in a renewal session that consisted in placing the rats in the S/A training context (CX A) 
and during which each NPL press resulted in a CS presentation. 
 
 
The total NPL presses at the end of the 180 minutes renewal session was 68.0 ± 0.6, 
51.5 ± 10.9, 55.6 ± 9.8, 53.7 ± 5.9 and 48.0 ± 2.0, 42.2 ± 10.9 (11.3 ± 2.0, 12.8 ± 4.1, 
20.0 ± 2.0, 9.3 ± 2.7, 12.0 ± 6.0 and 15.2 ± 5.2 inactive lever presses) (mean ± S.E.M.) 
respectively for Ret/Veh (n = 3), Ret/CS-Ext (n = 4), Ret/Prop (n= 5), No-Ret/Veh (n = 
3), No-Ret/CS-Ext (n = 2), No-Ret/Prop (n=5) groups (Figure 24). To compare the 
results of CS-extinction or propranolol vs. vehicle we run two separate two way 
ANOVA with factor retrieval (Ret, No-Ret) and factor treatment (CS-Ext or Prop and 
Veh). In the analysis comparing Cs-Ext vs.Veh two way ANOVA showed main effect 
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for factor treatment (CS-Ext, Veh) (F[1,3] = 10.98; p = 0.04)but not for factors retrieval 
(Ret, No-Ret) (F[1,3] = 0.49 ; p = 0.53) neither for interaction between retrieval and 
treatment (F[1,3] = 2.90; p = 0.19). Bonferroni post-hoc test did not revealed any 
difference between groups. In the analysis comparing Prop vs.Veh two way ANOVA 
showed no effect for factor treatment (Prop, Veh) (F[1,6] = 3.36; p = 0.11)for factors 
retrieval (Ret, No-Ret) (F[1,6] = 1.22 ; p = 0.31) neither for interaction between retrieval 
and treatment (F[1,6] = 0; p = 0.97). Bonferroni post-hoc test did not revealed any 
difference between groups.  
 
 
Figure 24: Total number of food-paired (NPL) lever presses at the end of renewal 
session in Experiment #3. Data are expressed as mean number of NPL presses ± S.E.M 
(Ret/Veh n=3; Ret/CS-Ext n=4; Ret/Prop n=5; No-Ret/Veh n=3; No-Ret/CS-Ext n=3; 
No-Ret/Prop n=4). Two way ANOVA revealed a main effect of CS-extinction but not 
of propranolol. Bonferroni post-hoc test did not revealed any significant difference 
between groups. 
 
 
Temporal analyses of cumulative NPL responding during the renewal session were 
performed at different time-points separately for each Ret and No-Ret groups. For Ret 
groups (Figure 25), two way ANOVA analyses for factor treatment at two levels (CS-
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Ext, Veh) and time-point (i.e., at 180, 120, 60, 45, 30 min) showed statistically 
significant main effects of both time-point (F[5,25] = 48.19; p < 0.0001)  and treatment 
(F[1,25] = 6.72; p = 0.048). No significant effect for interaction between factors was 
observed (F[5,25] = 1.35; p =0.28). Bonferroni post-hoc test did not show any difference 
between groups. Two way ANOVA analyses for factor treatment at two levels (Prop, 
Veh) and time-point (i.e., at 180, 120, 60, 45, 30 min) showed statistically significant 
main effects of both time-point (F[5,30] = 45.97; p < 0.0001). No significant effect was 
observed for factor treatment (F[1,30] = 0.23; p = 0.64) and for interaction between 
factors was observed (F[2,30] = 2.30; p =0.07). Bonferroni post-hoc test did not show any 
difference between groups. 
 
 
Figure 25: Temporal analysis of renewal for Ret groups in Experiment #3. Data are 
expressed as number of NPL (mean ± S.E.M) at different time-points of the renewal 
session. Two way ANOVA revealed a main effect of CS-extinction but not of 
propranolol. Bonferroni post-hoc test did not revealed any significant difference 
between groups. 
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For No-Ret group (Figure 26), two way ANOVA analyses for factor treatment at two 
levels (CS-Ext, Veh) and time-point (i.e., at 180, 120, 60, 45, 30 min) showed 
statistically significant main effects of time-point (F[5,20] = 27.11; p < 0.0001) but not for 
factor treatment (F[1,20] = 2.81; p = 0.17) neither for interaction between factors (F[5,20] = 
1.41; p = 0.26). Bonferroni post-hoc test did not show any difference between groups. 
Two way ANOVA analyses for factor treatment at two levels (Prop, Veh) and time-
point (i.e., at 180, 120, 60, 45, 30 min) showed statistically significant main effects of 
time-point (F[5,25] = 4.97; p < 0.003) but not for factor treatment (F[1,25] = 0.20; p = 0.67) 
neither for interaction between factors (F[5,25] = 0.70; p = 0.63). Bonferroni post-hoc test 
did not show any difference between groups 
 
 
Figure 26: Temporal analysis of renewal for No-Ret groups in Experiment #3. Data are 
expressed as number of NPL (mean ± S.E.M) at different time-points of the renewal 
session. No effect CS-extinction or 13propranolol have been observed. 
 
 
In summary in the analysis taking in consideration the retrieved group (Ret/Veh and 
Ret/CS-Ext) two way ANOVA for factor time point and factor treatment (CS-
extinction, vehicle) showed a main effect of treatment. On the other hand in the analysis 
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taking in consideration the no-retrieved group (No-Ret/Veh and No-Ret/CS-Ext) two 
way ANOVA for factor time point at different levels (30, 45, 60, 120 and 180 minutes) 
and factor treatment (CS-extinction, vehicle) showed no effect of treatment. No effect 
of propranolol was observed across either in retrieved and in no-retrieved groups 
(Ret/Veh, Ret/Prop or No-Ret/Veh, No-Ret/Prop). 
At all time-points during the 180 minutes session, the six groups exhibited a 
significantly greater responding on NPL than on inactive lever (statistical analysis not 
shown).  
 
3.2.4. Experiment #4 
 
Figure 27: Schematic diagram of experimental design in experiment #4. Rats were 
trained to nicotine self-administration (S/A) (approximately 14 sessions) then they 
underwent an instrumental extinction (ILEXT) phase in order to extinguish the 
instrumental learning component of conditioning (approximately 11 sessions). 1 day 
after the end ILEXT rats were divided into four groups that were exposed to 0, 3, 30 or 
300 CS presentations respectively in a context other to the S/A and ILEXT phases (CX 
B). The day after, memory were tested in a renewal session that consisted in placing the 
rats in the S/A and ILEXT context (CX A) and during which each NPL press resulted in 
a CS presentation. 
 
 
The total NPL presses at the end of the 180 minutes renewal session was 81.0 ± 29.0, 
144.0 ± 19.4, 58.2 ± 24.7 and 47.0 ± 9.0 (4.5 ± 2.0, 6.5 ± 0.8, 7.5 ± 3.2 and 12.5 ± 1.9 
inactive lever presses/session) (mean ± S.E.M.) respectively for 0CS  (n = 4), 3CS (n = 
4), 30CS (n= 4) and 300CS (n = 4) groups (Figure 28). One way ANOVA showed no 
significant main effect for factors CS presentation (0CS, 3CS, 30CS an 300CS). 
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Figure 28: Total number of nicotine-paired (NPL) at the end of renewal session in 
Experiment #4. Data are expressed as mean number of NPL presses ± S.E.M. No 
difference between groups has been observed. (n=4 per group). 
 
 
Temporal analyses of cumulative NPL responding during the renewal session were 
performed at different time-points (Figure 29). Two way ANOVA analyses for factor 
CS presentations at four levels (0CS, 3CS, 30CS an 300CS) and time-point (i.e., at 15, 
30, 45, 60, 120, 180 minutes) showed statistically significant main effects of time-point 
(F[5,55] = 12.89; p < 0.0001), but not of and CS presentations (F[3,55] = 2.02; p = 1.69), 
neither for interaction between factors was observed (F[15,55] = 1.12; p = 0.36). 
Bonferroni post-hoc test did not show any difference between groups. 
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Figure 29: Temporal analysis of renewal in Experiment #4. Data are expressed as 
number of NPL (mean ± S.E.M) at different time-points of the renewal session. No 
difference between groups has been observed. However 300 CS presentations tend to 
decrease the number of NPL presses across the entire session. (n=4 per group). 
 
 
In summary no statistically significant effect was observed. However 300CS 
presentation tend to decrease the number of NPL presses during the entire renewal 
session. At all time-points during the 180 min session, the four groups exhibited a 
significantly greater responding on NPL than on inactive lever (statistical analysis not 
shown).  
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3.2.5 Experiment #5 
 
Figure 30: Schematic diagram of experimental design in experiment #5. Rats were 
trained to nicotine self-administration (S/A) (approximately 13 sessions), and then they 
underwent an instrumental extinction phase (ILEXT, approximately 12 sessions) in 
order to extinguish the instrumental component of conditioning. One day after the end 
of ILEXT, rats were divided into two groups that underwent a retrieval or no-retrieval 
session respectively in a context other then the S/A and ILEXT one (CX B). Then both 
Ret and No-Ret groups were divided into three subgroups. Ret/CS Ext and No-Ret/CS-
Ext, one hour after the end of retrieval, underwent a CS-extinction session in which CS, 
but not nicotine was presented upon NPL press. Session lasted until the extinction of 
response (no NPL presses for 30 minutes) and took place in CXB. Ret/MK801 and No-
Ret/MK801 30 minutes before the retrieval or no-retrieval received a MK801 injection. 
Ret/Veh and No-Ret/Veh 30 minutes before retrieval or no-retrieval received an 
injection of water Milli-Q (vehicle). The day after, memory were tested in a renewal 
session that consisted in placing the rats in the S/A training context (CXA) and during 
which each NPL press resulted in a CS presentation. 
 
 
The total NPL presses at the end of the 180 min renewal session was 46.0 ± 10.7, 38.7 ± 
6.2, 81,2±15, 52.5 ± 8.4, 45.5 ± 10.8 and 60 ± 13 NPL presses/180 min (3.8 ± 0.5, 5.2 ± 
1.5,3.6 ± 0.9, 8.2 ± 2.3, 6.0 ± 0.9 and 5.4 ± 1.8 inactive lever presses/180 min session) 
(mean ± S.E.M.) respectively for Ret/Veh (n = 9), Ret/CS-Ext (n = 13), Ret/MK801 
(n=13) No-Ret/Veh (n = 13), No-Ret/CS-Ext (n = 12) and No-Ret/MK801 (n=13) 
groups (Figure 31). To compare the results of CS-extinction or MK801 vs. vehicle 
separately we run two separate two way ANOVA with factor retrieval (Ret, No-Ret) 
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and factor treatment (CS-Ext or MK801 and Veh). In the analysis comparing CS-Ext 
vs.Veh, two way ANOVA did not showed any significant effect for factor treatment 
(Veh, CS-Ext) (F[1,43] = 0.64; p = 0.43), not for factors retrieval (Ret, No-Ret) (F[1,67] = 
0.01; p = 0.91) neither for the interaction between retrieval and treatment (F[1,43] = 0.00; 
p = 0.99). In the analysis comparing MK801 vs.Veh, two way ANOVA did not showed 
any significant effect for factor treatment (Veh, MK801) (F[1,44] = 2.82; p = 0.10), not 
for factors retrieval (Ret, No-Ret) (F[1,44] = 0.14; p = 0.71) neither for the interaction 
between retrieval and treatment (F[1,44] = 0.77; p = 0.38). 
 
 
Figure 31: Total number of nicotine-paired (NPL) lever presses at the end of renewal 
session in Experimen #5. Data are expressed as mean number of NPL presses ± S.E.M. 
No difference between groups has been observed. (Ret/Veh n=9; Ret/CS-Ext n=13; 
Ret/MK801 n=13; No-Ret/Veh n=13; No-Ret/CS-Ext n=12; No-Ret/MK801 n=13). 
 
Temporal analyses of cumulative NPL responding during the renewal session were 
performed at different time-points separately for each Ret and No-Ret groups. For Ret 
groups (Figure 32), two way ANOVA analyses for factor treatment at two levels (CS-
Ext, Veh) and time-point at different levels (i.e., at 180, 120, 60, 45, 30 minutes) 
showed a statistically significant main effect of time-point (F[5,100] = 27.29; p < 0.0001; 
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F[4,80] = 19.77; p < 0.0001; F[3,60] = 13.53; p < 0.0001; F[2,40] = 10.34; p = 0.0002; F[1,20] = 
9.16; p = 0.0067) respectively, whereas a statistically significant main effect for factor 
treatment was observed only during the early part of the session, i.e. at 60, 45 and 30 
minutes (F[1,60] = 5.84; p = 0.02; F[1,40] = 7.70; p = 0.01; F[1,20] = 8.12; p = 0.0099) 
respectively. No significant effect for interaction between factors was observed at any 
time-point level. For Ret groups (Figure 32), two way ANOVA analyses for factor 
treatment at two levels (MK801, Veh) and time-point at different levels (i.e., at 180, 
120, 60, 45, 30 minutes) analyses showed a significant main effect for factor time-point 
at each level (F[5,100] = 21.55; p < 0.0001; F[4,80] = 18.06; p < 0.0001; F[3,65] = 15.75, p < 
0.0001; F[2,40] = 14.70; p < 0.0001; F[1,20] = 11.57; p = 0.003). On the other hand, 
treatment main effect was not observed when two way ANOVA analyses were 
performed at different time-point levels (6, 5, 4, 3 and 2 levels, i.e., at 180, 120, 60, 45, 
30 min) (F[1,100] = 0,60;  p = 0.45; F[1,80] = 0.05; p = 0.82; F[1,60] = 0.02, p = 0.88; F[1,40] = 
0.11; p = 0.75; F[1,20] = 0.19; p = 0.67) respectively.  No significant effect for interaction 
between factors was observed at any time-point level. 
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Figure 32: Temporal analysis of renewal for Ret groups in Experiment #5. Data are 
expressed as number of NPL (mean ± S.E.M) at different time-points of the renewal 
session. Two way ANOVA for factor time point at 4, 3 and 2 levels (60, 45 and 30,15 
minutes; 45, 30, 15 minutes; 30, 15 minutes, respectively) and factor treatment at two 
levels (CS-Ext, Veh or MK801, Veh) revealed a main effect of CS-extinction in the 
early part of the session. No effect of MK801 was observed. *p<0.05 main effect of 
treatment, two way ANOVA with factor time-point  and treatment at two levels (Cs-
EXT, Veh), **p<0.01 main effect of treatment, two way ANOVA with factor time-
point  and treatment at two levels (Cs-EXT, Veh).  
 
 
For No-Ret groups (Figure 33), analyses for factor treatment at two levels (CS-Ext, 
Veh) and time-point at different levels (i.e., at 180, 120, 60, 45, 30 minutes) showed a 
significant main effect for factor time-point at each level (F[5,115] = 40.45; p < 0.0001; 
F[4,92] = 35.46; p < 0.0001; F[3,69] = 19.28, p < 0.0001; F[2,46] = 150.24; p < 0.0001; F[1,23] 
= 13.21; p = 0.0014). On the other hand, treatment main effect was not observed when 
two way ANOVA analyses were performed at different time-point levels (6, 5, 4, 3 and 
2 levels, i.e., at 180, 120, 60, 45, 30 minutes) (F[1,115] = 0.41;  p = 0.53; F[1,92] = 0.46; p = 
0.50; F[1,69] = 0.68, p = 0.42; F[1,46] = 0.66; p = 0.42; F[1,23] = 0.58; p = 0.45) 
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respectively.  No significant effect for interaction between factors was observed at any 
time-point level.  
For No-Ret groups (Figure 33), two way ANOVA analyses for factor treatment at two 
levels (MK801, Veh) and time-point at different levels (i.e., at 180, 120, 60, 45, 30 
minutes) showed a significant main effect for factor time-point at each level (F[5,120] = 
32.67; p < 0.0001; F[4,96] = 29.68; p < 0.0001; F[3,72] = 22.87, p < 0.0001; F[2,48] = 18.92; 
p < 0.0001; F[1,24] = 18.51; p = 0.0002). On the other hand, treatment main effect was 
not observed when two way ANOVA analyses were performed at different time-point 
levels (6, 5, 4, 3 and 2 levels, i.e., at 180, 120, 60, 45, 30 min) (F[1,120] = 0.14;  p = 0.71; 
F[1,96] = 0.03; p = 0.86; F[1,722] = 0.00, p = 0.98; F[1,48] = 0.00; p =0.98; F[1,24] = 0.00; p = 
0.95) respectively.  No significant effect for interaction between factors was observed at 
any time-point level. 
 
 
Figure 33: Temporal analysis of renewal for No-Ret groups in Experiment #5. Data are 
expressed as number of NPL (mean ± S.E.M) at different time-points of the renewal 
session. No effect of Cs-extinction or MK801 has been observed.  
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In summary in the analysis taking in consideration the retrieved group (Ret/Veh and 
Ret/CS-Ext) two way ANOVA for factor time point at different levels (30, 45, 60, 120 
and 180 minutes) and factor treatment (CS-extinction, vehicle) showed a main effect of 
treatment in the early phase of renewal session (60, 45 and 30 minutes). On the other 
hand in the analysis taking in consideration the no-retrieved group (No-Ret/Veh and 
No-Ret/CS-Ext) two way ANOVA for factor time point at different levels (30, 45, 60, 
120 and 180 minutes) and factor treatment (CS-extinction, vehicle) showed no effect of 
treatment. No effect of MK801 was observed across either in retrieved and in no-
retrieved groups (Ret/Veh, Ret/MK801 or No-Ret/Veh, No-Ret/MK801). 
At all time-points during the 180 min session, the six groups exhibited a significantly 
greater responding on NPL than on inactive lever (statistical analysis not shown).  
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4. DISCUSSION 
 
Figura 34: Schematic diagram of project design and main results.  
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In this project we have investigated whether post-retrieval treatment, such as 
propranolol, MK-801 or CS-extinction were able to prevent the renewal of food or 
nicotine-seeking behaviour in an animal model of nicotine addictive behaviour. We 
have applied these treatments after different retrieval lengths (30, 1 and 3 CS 
presentations in Experiment #1 and #2, Experiment #3, Experiment #5 respectively). 
The results can be summarized as follows: i) renewal of nicotine-seeking behaviour 
have been impaired by the administration of CS-extinction after a short retrieval (1 or 3 
CS presentations), on the other hand no effect of CS-extinction has been observed in 
those subjects without retrieval; ii) renewal of food seeking behaviour have been 
impaired by the administration of CS-extinction either with or without a previous long 
retrieval (30 CS presentations); iii) propranolol and MK-801 have had no effect on of 
food or nicotine seeking behaviour.  
In the first experiments we were interested to assess whether the update of the nicotine 
memories by their retrieval could enhance the efficacy of CS-extinction procedure in 
inhibiting the renewal of nicotine seeking behaviour. This is based on the idea that new 
information, provided while memories are labile due to retrieval, could be incorporated 
in the original memory trace. Therefore we hypothesized that the CS-No US associative 
information provided through CS-extinction would be integrated in the original CS-US 
associative memories, leading to a disruption of the conditioned values of CS, and 
therefore resulting in inhibition of renewal of nicotine-seeking behaviour triggered by 
CS presentation. CS-extinction per se is a new learning process, and does not delete the 
original memory but compete with it. It has been argued that updating the original 
memories trace, instead of creating a new one, could be more effective in preventing the 
re-expression the original memory (Monfils et al, 2009 and Schiller et al, 2011). 
However our results showed that the administration of the CS-extinction after retrieval 
did not increase the effect of CS-extinction when applied alone. This is in contrast with 
the data obtained by Monfils et al and Schiller et al. They have show in an animal and 
human model of fear conditioning respectively, that the CS-extinction provided within 
the reconsolidation window of fear related memories could disrupt their reconsolidation 
and prevent the return of fear. On the other hand our results are in line with the finding 
that post-retrieval CS-extinction do not prevent the return of fear both in animal and 
human model of fear conditioning (Chan et al, 2011; Costanzi et al, 2011; Soeter & 
Kindt 2011). Recently also Flavell and colleagues (2011) showed that the combination 
of memory retrieval and extinction did not affect subsequent conditioned freezing 
 76 
compared with the control group given extinction alone in an auditory fear conditioning 
paradigm. However they pointed out that some methodological issues might explain the 
contrasting results with the original finding of Monfils et al (such as training length). 
However, in the same study, Flavell et al showed that post-retrieval extinction 
significantly impaired the contextual fear memory, compared to extinction alone. It 
should be taken in consideration that emotional and appetitive memories underlie on 
different memory system and mechanisms (Honjio et al., 2009), therefore this could 
explain the different results we obtained in nicotine self-administration paradigm, 
involving appetitive memories, and those obtained in fear conditioning paradigm (Chan 
et al, 2011; Costanzi et al, 2011; Flavell et al, 2011; Soeter & Kindt, 2011), involving 
emotional memories. However, Flavell et al have recently shown that post-retrieval-
extinction procedure is effective in disrupting appetitive (i.e. food-related) Pavlovian 
memories in rats: they have demonstrated that the combination of retrieval and 
extinction reduced the conditioned reinforcing values of the food-related memories 
when compared to extinction alone. It remains to be determined at which extent 
Pavlovian appetitive food memories undergo reconsolidation in a similar way to 
Pavlovian appetitive drug memories.   
It should be pointed out that, since Experiment #1 was a preliminary experiment, the 
number of replications was very low, therefore we decided to further investigate the 
effect of post-retrieval CS-extinction on renewal of food-seeking behaviour 
(Experiment #2). In the second experiment we included two groups of subjects treated 
with propranolol with or without previous retrieval of nicotine related memories, and 
two control groups treated with vehicle (retrieved and no-retrieved). Previous studies 
showed that propranolol administered in concomitance with appetitive memories 
retrieval may disrupt their reconsolidation (Diergaarde et al, 2006; Milton et al, 2008). 
We therefore have included propranolol as a pharmacological standard to assess 
whether 30 CS presentations at retrieval was able to induce reconsolidation. No effect 
of propranolol was observed; moreover CS-extinction reduced the renewal of food 
seeking behaviour both in retrieved and in no-retrieved subjects. These data suggest that 
our retrieval protocol was not inducing reconsolidation of food-memories. 
Flavell et al. have found that either retrieval consisting in 10-minute exposure to the 
context previously paired with food self-administration, and to the light CS in 
combination were both able to reactivate food related memories and, in combination 
with extinction, to produce a deficit in conditioned reinforcement compared to the 
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extinction controls. They argued that context alone might retrieve and destabilize the 
light (CS)-food memories. These data are consistent with our finding that CS-extinction 
reduce renewal of food seeking behaviour both with or without previous retrieval of 
food-seeking behaviour, considering that no-retrieval procedure consisted in placing the 
animal for 20 minutes in the “retrieval” context. The hypothetical context-induced 
retrieval of CS might explain the efficacy of CS-extinction in preventing the renewal of 
food-seeking behaviour both in retrieved subjects and in no-retrieved subjects. However 
our experiments retrieval and no-retrieval procedure were performed in a context other 
than the food-associated one, therefore is unlikely that context may retrieve light (CS)-
food association. Given the lack of effect of propranolol and the no specificity of CS-
extinction we hypothesized that retrieval protocol used (30 non contingent CS 
presentations) was not actually inducing destabilization of the memory and subsequent 
reconsolidation. The retrieval length (i.e. the number of CS presentations) is a critical 
factor on whether reconsolidation or extinction occurs: a short exposure to a previously 
conditioned stimulus act as retrieval of the CS-related memory, it induces the 
destabilization and subsequent reconsolidation of this memory trace, a long exposure to 
CS induce the extinction of this CS (Monfils et al., 2009; Pedreira & Maldonado 2003). 
We speculated that 30 CS presentations could induce extinction, instead of 
reconsolidation; therefore we decided to test the effect of CS-extinction and propranolol 
applied after a shorter retrieval (1 CS presentation) on renewal of nicotine-seeking 
behaviour (Experiment #3). As for the previous experiment we observed that retrieval 
before CS-extinction did not potentiate the effect of CS-extinction alone (after no-
retrieval session) and propranolol did not prevent renewal either with or without 
previous retrieval of the memory. The lack of effect of propranolol on food or nicotine-
related memories is in contrast with previous studies in which it has been shown that 
propranolol disrupt the reconsolidation of food and drug related memory in rats 
(Diergaarde et al, 2006; Milton et al, 2008). Some protocols differences between these 
studies should be pointed out. The study carried out by Milton et al. was conducted in a 
procedure (namely acquisition of new response for conditioned reinforcer, described in 
Lee et al., 2005) that isolates the acquired Pavlovian conditioned reinforcing properties 
of appetitive conditioned stimuli (i.e. the association CS-US), from the instrumental 
component of the conditioning (i.e. the association conditioned response-US). A 
limitation of our study is that, during retrieval, instrumental component of appetitive 
memories were not be reactivated (and then supposed to be disrupted by propranolol or 
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CS-extinction), since the CS were presented not contingently upon response and levers 
were not present in the retrieval context, therefore it cannot be excluded that renewal of 
food and nicotine related memories were triggered by instrumental memories instead of 
Pavlovian memories.  
In study carried out by Diergaarde et al, retrieval consisted in the exposure to context 
previously associated to the sucrose self-administration without the presentation of the 
tone and cue-light (CSs) previously associated to sucrose availability, therefore only the 
contextual memory was destabilized at retrieval. Propranolol was administered at the 
same dose used in our protocol immediately after retrieval. It can be argued that 
propranolol have selectively disrupted the reconsolidation of the contextual memory 
resulting in the prevention of context-induced reinstatement of sucrose seeking-
behaviour. In our experiment, retrieval consisted in the presentation of the cue-light 
(CS) previously paired with food delivery and took place in a context other than the 
conditioned one, therefore the context related memories could not be destabilized by 
retrieval and subsequently disrupted by propranolol. Therefore it is possible that 
contextual memories, instead of the retrieved CS-memories, were responsible for the 
renewal of food or nicotine seeking behaviour in our experiments. We choose to apply 
retrieval (and also CS-extinction) in a new context to improve the face validity of our 
experimental design, in a translational perspective. In the real life smoking-cessation 
treatments are provided by doctors at the hospital, therefore in a context different from 
that associated with the drug intake. It is well known that drug-related context may 
trigger the craving for smoking and precipitate relapse (Conklin & Tiffany, 2001). Find 
a treatment that generalize from clinical setting to real life would be fundamental for the 
development of new therapeutic intervention for smoking cession, therefore we decided 
to test the efficacy of retrieval-CS-extinction when it is applied in a context other then 
the drug-related one. 
The efficacy of propranolol in the memory reconsolidation blockade has demonstrated 
also in different experimental paradigms: Zhao et al (2011) have shown that the 
administration of propranolol prior to retrieval of heroin-related declarative memories 
may inhibit their reconsolidation in heroin addicts. Debiec & LeDoux  (2004) and 
Abrari et al (2008) showed that propranolol administered in combination to retrieval 
disrupts both auditory and contextual fear conditioning respectively; Kindt et al in two 
studies (Soeter  & Kindt, 2011; Kindt & Soeter, 2011) have shown that fear related 
memories could be disrupted by the administration of propranolol upon retrieval in a 
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human model of PTDS. On the other hand, other Authors reported a limited efficacy of 
propranolol on the reconsolidation of fear memories (Muriavieva & Alberini, 2010: 
Tollenaar 2008). However, as stated above, in comparing different studies analyzing the 
effect of propranolol on memory reconsolidation, we should keep in mind the different 
nature of emotional, declarative and appetitive memories. 
Our data showing no effect of post-retrieval propranolol administration on appetitive 
memories reconsolidation are in agreement to findings of Lee et al (2008) and Milton et 
al (2011). They have demonstrated that propranolol did not disrupt the reconsolidation 
of Pavlovian conditioned approach (the phenomenon by which animals will approach a 
CS that has been associated with the presentation of the appetitive reinforce; Brown & 
Jenkins, 1968) and conditioned motivation (the phenomenon by which CS is also 
capable of invigorating instrumental behaviour) for the conditioned stimuli associated to 
sucrose or ethanol reinforcement respectively (for review see Milton & Everitt, 2010) .  
Previous studies by Bustos et al  (2009) and Suzuki et al (2004) have suggested that a 
very brief retrieval may not result in the memory destabilization and consequent 
reconsolidation, therefore we hypothesized that 1 CS presentation was to low for 
inducing retrieval of the memory. It is also possible the rat might miss the only CS 
presentation (1 second illumination of the cue-light), for example if they are looking on 
side of the cage opposite to the cue-light side. 
We therefore tested the effect of different retrieval length on renewal of nicotine-
seeking behaviour, in order to assess how many CS presentations induced extinction 
and how many did not induce any change in renewal compared to vehicle. Retrieval 
alone generally did not affect the conditioned response and the existence of a 
reconsolidation process is largely revealed by its absence, generally by its inhibition.  
Therefore, we hypothesized that 300 CS presentations would work as CS-extinction 
leading to a decrease of the conditioned response on renewal test, 30 CS presentations 
would lead to a lower decrease of the conditioned response and 3CS presentations 
would work as retrieval and would not have any effect on renewal. Moreover, since we 
were interested in study the Pavlovian CS-US association memory, we decided to 
include in the study protocol design an instrumental learning extinction phase prior of 
retrieval that allowed to control for the operant conditioning component of nicotine S/A 
and for the specificity of the CS-extinction and propranolol effect on nicotine Pavlovian 
memory. 300 CS presentations showed a trend to decrease (even if the effect is not 
statistically significant) the conditioned response during renewal compared to the 0 CS 
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presentation, suggesting that it worked as CS-extinction. 30 or 3 CS presentations did 
not affect the renewal of nicotine-seeking behaviour. On the basis of the data from these 
experiments (Experiment #1, #2, #3, #4) we decided to use 3 CS presentations as 
retrieval protocol in the next experiment.  
In Experiment #5 we assessed whether CS-extinction and MK-801 block the 
reconsolidation of nicotine-related memory when applied after retrieval constituted by 3 
non-contingent CS presentations. It has been shown that MK-801, an NMDA receptor 
antagonist, administered in concomitance of retrieval inhibit the reconsolidation of 
drug-related memories (van der Golz et al, 2009; Milton et al, 2008, 2011), therefore we 
have included MK-801 as a pharmacological standard to assess whether our retrieval 
condition induce destabilization of the memories. 
Post-retrieval nicotine CS-extinction significantly reduced renewal of nicotine-seeking 
behaviour compared to the control subjects that did not receive CS-extinction (Ret/Sal). 
On the other hand, no effect of CS-extinction was observed in those subjects without 
nicotine Pavlovian memory retrieval. Considering that the instrumental learning 
component of nicotine self-administration conditioning was extinguished, these findings 
suggest that the effect of post-retrieval nicotine CS-extinction on renewal was 
specifically due to inhibition of nicotine Pavlovian memory reconsolidation. To our 
knowledge, this is the first evidence of post-retrieval CS-extinction effect on drug-
seeking behaviour. Considering that this is an indirect demonstration of the occurrence 
of memory reconsolidation process, we would also consider the result of this 
experiment as the first evidence of nicotine Pavlovian memory reconsolidation. We 
have two lines of evidence that allow speculating that post-retrieval CS extinction 
interfered with the reconsolidation of nicotine CS-memory. First, in the groups where 
nicotine CS was not reactivated, the exposure to CS-extinction did not modify the 
nicotine seeking behaviour (i.e. NPL presses) compared to the control group no-
retrieved/vehicle (NoRet/Veh). Second, CS-extinction was applied within one 1 h from 
retrieval, during the so-called ‘reconsolidation window’ when memory enters in a 
vulnerable state (Duvarci & Nader, 2003). These data therefore suggest that there is a 
temporal labile window during which reactivated reinforcing drug memory could be 
inhibited by CS-extinction. The effects of this inhibition may reduce drug-seeking 
behaviour under renewal (CS re-presentation in the conditioning context after CS-
reactivation done in a different context), but also suggest that a similar effect may occur 
under other conditions such as reinstatement (when the US is unexpectedly re-
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presented) and spontaneous recovery (when CS is re-presented after a certain period of 
time), as reported for fear conditioning in rats (Monfils et al., 2009).  
Post-retrieval exposure to CS-extinction significantly reduced NPL responding on 
renewal session compared to the non CS-extinction condition. The effect was 
significant during the first hour of the renewal session and highly significant during the 
early 30 min phase. While the effects were only transient, the finding that renewal early 
in the session was suppressed only subject given CS-extinction in combination of 
retrieval suggests that processes that occur in early relapse to nicotine may be impaired.  
The mechanism through which post-reactivation CS-extinction interferes with 
reconsolidation is not clear yet. Although extinction is a learning process by which the 
CS becomes newly associated with no-outcomes leading to a decrease in the previously 
established response, in our study CS-extinction, without previous retrieval of the 
memory, is not however effective on renewal responding in the non-retrieved group. 
Thus, it seems that the new CS-extinction learning specifically affects the process 
activated after nicotine CS-reactivation. It is still unclear which mechanisms are 
involved in the ‘extinction vs. reconsolidation’ interaction. Some hypothesis have been 
proposed such as, i) CS-memory is updated during the labile phase with the new 
information acquired with CS-extinction (‘persistent revaluation’) or, ii) CS-extinction 
learning weakens and substitutes for the reactivated CS-memory (‘progressive 
deconsolidation’) (Monfils et al., 2009; Schiller et al. 2010). These two possible 
mechanisms have been demonstrated in human studies for forms of memory (Walker et 
al., 2003; Forcato et al., 2007; Hupbach et al., 2007) other than the appetitive memory 
investigated in our study. Therefore, further studies are needed in order to clarify the 
mechanism through which post-reactivation CS-extinction interferes with the 
reconsolidation of appetitive memory.  
However in this experiment (Experiment #5) MK-801 failed in inhibiting the 
reconsolidation of nicotine related memory. This result is in contrast with previous 
studies demonstrating that MK-801, given in conjunction with retrieval, disrupt the 
reconsolidation of conditioned place preference conditioned to cocaine (Kelley at al., 
2007; Brown et al., 2008; Itzhak, 2008), amphetamine (Sadler et al., 2007; Sakuarai et 
al., 2007) and morphine (Zhai et al., 2008). However it should be taken in consideration 
that self-administration likely produce a “stronger” memory then does conditioned place 
preference training because of the amount of number of pairing of drug with context 
and or CS in rats undergoing self-administration compared with conditioned place 
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preference, e.g. in conditioned place preference training described by Brown et al. 
(2008) rats received 4 cocaine-context pairing, in our self-administration training rates 
receive 200 nicotine-CS pairing. Several authors suggest that strong and old memories 
are less susceptible to post-retrieval manipulation (Frankland et al., 2006, Inda et al., 
2011; Suzuki et al., 2004) therefore the different memory strength between rats trained 
to self-administration and conditioned place preference could explained the contrasting 
results. However administration of MK-801 in combination to retrieval has been shown 
to disrupt drug-related memories reconsolidation also in tasks involving strong 
memories, such as cocaine, sucrose or alcohol self-administration. van der Goltz et al. 
(2009) showed that the systemic administration of MK-801 given in conjunction of 
retrieval, reduced alcohol seeking behaviour in animal trained to alcohol self-
administration, compared to a vehicle-treated control group. This effect was not 
observed when MK-801 was administered without retrieval of alcohol-related 
memories. The retrieval consisted in presenting the CS and the context previously 
paired with alcohol self-administration, whereas in our experiment retrieval consisted in 
the presentation CS and not of the context previously paired with nicotine self-
administration. Therefore, as discussed above, it is possible that contextual memories, 
instead of the retrieved CS-memories, were responsible for the renewal of nicotine 
seeking behaviour in our experiments. 
On the other hand our data are in agreement with those obtained by Wouda et al. (2010) 
and Brown et al. (2010). Wouda et al. showed that MK-801, administered after a single 
retrieval session did not reduce the reinstatement of alcohol seeking behaviour in rats 
trained to alcohol self-administration.  Notably they administered MK-801immediately 
following the retrieval procedure, while we gave MK-801 30 minutes prior retrieval. 
However, alcohol-seeking behaviour was significantly reduced after repeated post-
reactivation treatment (repeated reactivation followed by MK-801 injection). Brown et 
al. showed that post-retrieval MK-801 at the dose of 0.05 mg/Kg and also 0.2 mg/kg did 
not disrupt the reconsolidation of cocaine-associated memory in rats trained for cocaine 
self-administration.  
Notably our data are consistent with the previous finding of Lee & Everitt  (2008) 
showed that administration of MK-801 contingently upon retrieval (0,1 mg/kg, 30 
minutes prior retrieval as in our experiment) reduced sucrose seeking behaviour in a 
reinstatement test if, and only if, the CS were contingently presented, during the 
retrieval procedure. On the contrary no effect of MK-801 was observed when 
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administered in concomitance with non-contingent CS presentations. The latter data is 
consistent with our findings. Indeed in our retrieval protocol, CS was non-contingently 
presented.  
It has been recently pointed out that drug-related stimuli (CS) can influence 
instrumental drug-seeking (relapse) behaviour in at least three psychologically and 
neurobiologically distinct ways: by i), acting as conditioned reinforcers, ii), supporting 
Pavlovian conditioned approach (autoshaping or ‘sign tracking’) which engages 
attention to, and brings the individual into proximity with, locations where successful 
drug seeking and taking have occurred and iii), invigorating responding for drugs 
through their conditioned motivational properties (Pavlovian–instrumental transfer or 
PIT; Everitt et al. 2001; Milton and Everitt 2010). Systemic MK-801 have been shown 
to disrupt the reconsolidation of Pavlovian conditioned approach for CS associated to 
sucrose, cocaine or ethanol (Lee & Everitt, 2008b; Milton et al., 2008b; Milton et al., 
2011) and also conditioned motivation (PIT) for CS associated to cocaine or ethanol 
(Lee & Everitt, 2008b; Milton et al., 2011). As far as concerns the reconsolidation 
disruption of conditioned reinforcement, in the paradigm of acquisition of new 
instrumental response for conditioned reinforce, it has been shown that systemic MK-
801disrupted the conditioned reinforcing properties of CS previously paired to sucrose, 
whereas only intra-amygdala injection of MK-801 have been demonstrated to impair the 
reconsolidation of conditioned reinforcing values of CS previously associated to 
cocaine (Milton et al., 2008b). 
Literature reports on disruption of drugs of abuse memory reconsolidation have 
identified specific molecular and neuroanatomical mechanisms as targets of drug 
treatment, i.e. NMDA receptor and β-adrenergic receptor (Diergaarde et al., 2008; 
Milton & Everitt, 2010). Similar future research should identify the potential 
mechanisms for post-retrieval extinction effect on memory reconsolidation and may 
therefore suggest extinction as an alternative or a co-adjuvant to pharmacological 
disruption of appetitive memory reconsolidation. Given the importance of NMDA 
receptor in learning and memory it would worth to further investigate its potential role 
in mediating the effect of post-retrieval extinction on this receptor.  It has been 
demonstrated that NMDA antagonists, such as MK-801 and D-APV, may block the 
reconsolidation of the previously retrieved memory therefore we can speculate that also 
the effect of post-retrieval CS-extinction might be mediated by NMDA receptor. More 
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research is needed to better understand the molecular mechanisms underlying the effect 
of post-retrieval CS-extinction.  
 
4.1.Conclusion 
Our findings suggest that the exposure to nicotine CS-extinction, after a short retrieval 
of the same nicotine CS memory, may inhibit CS-induced conditioned responses of 
nicotine-seeking behaviour.  
The overall project has some limitations. First of all, as suggested above, it would be 
important to extend the assessment of post-reactivation nicotine CS-extinction effects to 
other tests of nicotine-seeking behaviour such as reinstatement and spontaneous 
recovery.  More than one test session on different days following the reactivation may 
test the time persistence of reconsolidation inhibition (e.g., Lee at al., 2006; Milton et al. 
2008a).  
Secondly, more evidences are needed to confirm that the effect of post-retrieval CS-
extinction were due to interference of CS-extinction with reconsolidation process. 
Further studies will investigate the effect of CS-extinction applied 6 hours after 
retrieval, a delay time that allow to apply CS-extinction outside the reconsolidation 
window. In a group in which CS-extinction is applied outside the reconsolidation 
window, subject will have equal handling and experience in the retrieval and CS-
extinction associated context compared to the group in which CS-extinction is applied 
within the reconsolidation window (1 hour after retrieval). This will allow us to better 
assess whether the effect of CS-extinction is retrieval-dependent or not. Moreover it 
would be fundamental to identify specific molecular markers of reconsolidation or 
extinction. To find a selective molecular correlate of reconsolidation will allow to 
disentangle the point of whether our retrieval protocols is inducing reconsolidation or 
extinction and will provide further evidence that post-retrieval CS-extinction interfere 
with reconsolidation of CS-memory. 
Third, it remains unclear the fact that MK-801 administered in concomitance of 
retrieval, failed to reduce the renewal of nicotine seeking behaviour. Methodological 
issues might be responsible of the different data found in literature. Identify a molecular 
marker specifically activated at retrieval might be useful to better understand the lack of 
effect of MK-801. 
Fourth, as pointed out by Lee & Everitt (2008), to successfully reactivate a memory 
acquired instrumentally (e.g. lever press) the CS should be presented contingently upon 
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acquired response. We can then hypothesized that presenting the CS contingently upon 
lever presses during retrieval session, would lead to a more complete retrieval and 
destabilization of the memories, and to a stronger effect of CS-extinction (and MK-801) 
on the reconsolidation of that memory.  
Finally, it remains unexplained the fact that the inhibition of renewal responding in the 
retrieved CS-extinction group is not greater than 50%. This may be due to i), limited 
efficacy of post-retrieval CS-extinction, ii), partial activation of reconsolidation 
mechanisms by our retrieval conditions (Lee, 2008; Wang et al., 2009), and/or the 
existence of other conditions under which reconsolidation does not fully take place 
(‘boundary’ conditions; Lee, 2009), iv), incomplete extinction of the instrumental 
learning component of nicotine S/A conditioning (e.g., Hernandez & Kelley, 2004), or, 
v), combinations of the conditions above. Notably, other factors may be taken into 
consideration such as the nicotine memory strength and age (Suzuki et al., 2004). On 
the latter issue, we however used experimental conditions for reinforcing drug/CS 
memory strength (total number of nicotine/CS associations) and age (duration of 
nicotine S/A training phase) similar to other papers (Sanchez et al., 2010). 
Therefore further studies are needed to better understand the mechanisms underlying the 
effect of CS-extinction on nicotine related memories and to optimize its efficacy in 
preventing the relapse of nicotine seeking behaviour. To achieve these objectives we 
will perform three sets of experiments. 
First of all the effect of CS-extinction, applied 6 hours after retrieval (outside the 
reconsolidation window), on renewal of nicotine seeking behaviour will be tested. 
Moreover this effect will be investigated on reinstatement and spontaneous recovery.  
Second, the effect of Cs-extinction (and MK-801), applied after a contingent CS 
presentation at retrieval, will be assessed.  
Finally we will perform ex-vivo molecular experiments after retrieval session. 
Molecular markers correlating reconsolidation needs to be assessed to confirm memory 
reconsolidation occurrence and its disruption. rpS6P is a new molecular marker taken in 
consideration in memory reconsolidation field. Recent studies from Hoeffler and Klann 
(REF) suggest that mTOR activation is involved in memory consolidation through 
eIF4F complex formation and in memory reconsolidation through rpS6 
phosphorylation. rpS6P is the final step of a “molecular cascade” and could be very 
specific in the identification of memory reconsolidation process. rpS6P is part of the 
ribosome and is ubiquitous so double labelled immunofluorescence allows to identify 
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neurons expressing rpS6P. In our laboratory we are going to standardize 
immunofluorescence as a qualitative assay and immunohistochemistry as a quantitative 
assay for rpS6P. 
 
In conclusion, our findings suggest that the exposure to nicotine CS-extinction, after a 
short retrieval of the same nicotine CS, may inhibit CS-induced conditioned responses 
of nicotine seeking and offer a potential co-adjuvant to current therapeutic 
interventions.  
 Current pharmacotherapy and behavioural support to aid smoking cessation are 
targeted at the early weeks post-quit when withdrawal symptoms are at a peak and 
individuals are particularly vulnerable to relapse. However, many smokers who 
successfully maintain abstinence through this early phase of a quit attempt, relapse at a 
later date. This highlights the importance of developing new interventions targeted at 
relapse prevention beyond the current treatment phase.  Exposure to drug-related cues 
and retrieval of drug-related memories are potent triggers of relapse, even after months 
of abstinence (Abrams, 1999) therefore there is an increasing interest across authors in 
developing novel treatments for addiction through manipulations of drug related 
memories. The first strategy to achieve this objective is to facilitate extinction; the 
second is to disrupt drug related memories reconsolidation. Although preclinical studies 
show promising results in the efficacy of reconsolidation-targeted treatment in 
preventing the relapse to drug-seeking behaviour, the reconsolidation of drug related 
memories in human have not yet been investigated. This is probably due to the fact that 
most of the compound used in animal studies to block memory reconsolidation can not 
be used in human, since they are toxic. Therefore the identification of a safe drug free 
paradigm, such that proposed in the present research project that inhibit reconsolidation 
of drug related memories would be critical for the future development of 
reconsolidation targeted therapy for smoking cessation. 
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